Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for WRNIP1
Z-value: 2.78
Motif logo
Transcription factors associated with WRNIP1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
WRNIP1
|
ENSG00000124535.16 | WRNIP1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| WRNIP1 | hg38_v1_chr6_+_2765361_2765563 | -0.20 | 2.9e-01 | Click! |
Activity profile of WRNIP1 motif
Sorted Z-values of WRNIP1 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of WRNIP1
| Promoter | Score | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr19_-_51001591 | 29.28 |
ENST00000391806.6
|
KLK8
|
kallikrein related peptidase 8 |
| chr19_-_51001668 | 25.91 |
ENST00000347619.8
ENST00000291726.11 ENST00000320838.9 |
KLK8
|
kallikrein related peptidase 8 |
| chr19_-_50968125 | 25.77 |
ENST00000594641.1
|
KLK6
|
kallikrein related peptidase 6 |
| chr19_-_50968775 | 24.98 |
ENST00000391808.5
|
KLK6
|
kallikrein related peptidase 6 |
| chr19_-_51001138 | 21.71 |
ENST00000593490.1
|
KLK8
|
kallikrein related peptidase 8 |
| chr19_+_35154715 | 18.02 |
ENST00000392218.6
ENST00000543307.5 ENST00000392219.7 ENST00000541435.6 ENST00000590686.5 ENST00000342879.7 ENST00000588699.5 |
FXYD5
|
FXYD domain containing ion transport regulator 5 |
| chr19_-_50983815 | 17.08 |
ENST00000391807.5
ENST00000593904.1 ENST00000595820.6 |
KLK7
|
kallikrein related peptidase 7 |
| chr19_-_50968966 | 15.33 |
ENST00000376851.7
|
KLK6
|
kallikrein related peptidase 6 |
| chr19_+_35154914 | 14.77 |
ENST00000423817.7
|
FXYD5
|
FXYD domain containing ion transport regulator 5 |
| chr8_-_23404076 | 13.57 |
ENST00000524168.1
ENST00000389131.8 ENST00000523833.2 ENST00000519243.1 |
LOXL2
|
lysyl oxidase like 2 |
| chr19_-_51002527 | 13.53 |
ENST00000595238.1
ENST00000600767.5 |
KLK8
|
kallikrein related peptidase 8 |
| chr1_-_205422050 | 13.30 |
ENST00000367153.9
|
LEMD1
|
LEM domain containing 1 |
| chr19_-_50953093 | 13.18 |
ENST00000593428.5
|
KLK5
|
kallikrein related peptidase 5 |
| chr18_+_49562049 | 12.46 |
ENST00000261292.9
ENST00000427224.6 ENST00000580036.5 |
LIPG
|
lipase G, endothelial type |
| chr1_+_20589044 | 12.45 |
ENST00000375071.4
|
CDA
|
cytidine deaminase |
| chrX_-_107777038 | 12.19 |
ENST00000480691.2
ENST00000506081.5 ENST00000514426.1 |
TSC22D3
|
TSC22 domain family member 3 |
| chr19_-_50984028 | 11.65 |
ENST00000597707.5
|
KLK7
|
kallikrein related peptidase 7 |
| chr1_-_20486197 | 11.35 |
ENST00000375078.4
|
CAMK2N1
|
calcium/calmodulin dependent protein kinase II inhibitor 1 |
| chr8_-_143568854 | 10.26 |
ENST00000524906.5
ENST00000532862.1 ENST00000534459.5 |
MROH6
|
maestro heat like repeat family member 6 |
| chr15_-_89496574 | 10.19 |
ENST00000268122.9
|
RHCG
|
Rh family C glycoprotein |
| chr2_+_209424039 | 9.96 |
ENST00000682079.1
ENST00000199940.10 |
MAP2
|
microtubule associated protein 2 |
| chr1_+_150549734 | 9.59 |
ENST00000674043.1
ENST00000674058.1 |
ADAMTSL4
|
ADAMTS like 4 |
| chr8_-_7416863 | 9.38 |
ENST00000318157.3
|
DEFB4B
|
defensin beta 4B |
| chr7_-_102611591 | 9.32 |
ENST00000461209.5
|
RASA4
|
RAS p21 protein activator 4 |
| chr12_-_24903014 | 9.30 |
ENST00000539282.5
|
BCAT1
|
branched chain amino acid transaminase 1 |
| chr12_-_47079859 | 9.19 |
ENST00000266581.4
|
AMIGO2
|
adhesion molecule with Ig like domain 2 |
| chr19_+_50649445 | 9.15 |
ENST00000425202.6
|
C19orf81
|
chromosome 19 open reading frame 81 |
| chr20_-_54173516 | 9.15 |
ENST00000395955.7
|
CYP24A1
|
cytochrome P450 family 24 subfamily A member 1 |
| chr11_-_111912871 | 9.12 |
ENST00000528628.5
|
CRYAB
|
crystallin alpha B |
| chr20_+_35172046 | 9.10 |
ENST00000216968.5
|
PROCR
|
protein C receptor |
| chr7_-_41700583 | 9.09 |
ENST00000442711.1
|
INHBA
|
inhibin subunit beta A |
| chr6_-_30686624 | 9.08 |
ENST00000274853.8
|
PPP1R18
|
protein phosphatase 1 regulatory subunit 18 |
| chr16_+_66604100 | 9.05 |
ENST00000562357.5
ENST00000562707.5 ENST00000361909.8 ENST00000460097.5 ENST00000565666.5 |
CMTM3
|
CKLF like MARVEL transmembrane domain containing 3 |
| chr19_-_50953063 | 9.04 |
ENST00000391809.6
|
KLK5
|
kallikrein related peptidase 5 |
| chr1_-_28176665 | 8.95 |
ENST00000373857.8
|
PTAFR
|
platelet activating factor receptor |
| chr2_+_64453969 | 8.81 |
ENST00000464281.5
|
LGALSL
|
galectin like |
| chr19_-_55149193 | 8.77 |
ENST00000587758.5
ENST00000588981.6 ENST00000356783.9 ENST00000291901.12 ENST00000588426.5 ENST00000536926.5 ENST00000588147.5 |
TNNT1
|
troponin T1, slow skeletal type |
| chr19_-_55146894 | 8.74 |
ENST00000585321.6
ENST00000587465.6 |
TNNT1
|
troponin T1, slow skeletal type |
| chr8_-_132085655 | 8.73 |
ENST00000262283.5
|
ENSG00000258417.3
|
novel protein |
| chr13_-_20232303 | 8.73 |
ENST00000400065.7
ENST00000643121.1 ENST00000647029.1 ENST00000643211.1 ENST00000400066.8 ENST00000644283.1 |
GJB6
|
gap junction protein beta 6 |
| chr8_+_85463997 | 8.71 |
ENST00000285379.10
|
CA2
|
carbonic anhydrase 2 |
| chr1_-_205449924 | 8.69 |
ENST00000367154.5
|
LEMD1
|
LEM domain containing 1 |
| chr1_-_205455954 | 8.68 |
ENST00000495594.2
ENST00000629624.2 |
LEMD1
BLACAT1
|
LEM domain containing 1 bladder cancer associated transcript 1 |
| chrX_-_38220824 | 8.60 |
ENST00000378533.4
ENST00000432886.6 ENST00000544439.5 ENST00000538295.5 |
SRPX
|
sushi repeat containing protein X-linked |
| chr8_+_7894674 | 8.42 |
ENST00000302247.3
|
DEFB4A
|
defensin beta 4A |
| chr19_-_35528221 | 8.39 |
ENST00000588674.5
ENST00000452271.7 ENST00000518157.1 |
SBSN
|
suprabasin |
| chr19_-_51342130 | 8.34 |
ENST00000335624.5
|
VSIG10L
|
V-set and immunoglobulin domain containing 10 like |
| chr19_-_50969567 | 8.09 |
ENST00000310157.7
|
KLK6
|
kallikrein related peptidase 6 |
| chr19_-_42855691 | 8.08 |
ENST00000401467.6
|
PSG8
|
pregnancy specific beta-1-glycoprotein 8 |
| chr19_-_51034727 | 8.01 |
ENST00000525263.5
|
KLK12
|
kallikrein related peptidase 12 |
| chr12_+_4269771 | 7.72 |
ENST00000676411.1
|
CCND2
|
cyclin D2 |
| chr19_+_38335775 | 7.70 |
ENST00000410018.5
ENST00000409235.8 ENST00000409410.6 |
CATSPERG
|
cation channel sperm associated auxiliary subunit gamma |
| chr6_+_151240368 | 7.67 |
ENST00000253332.5
|
AKAP12
|
A-kinase anchoring protein 12 |
| chr12_-_47079926 | 7.66 |
ENST00000429635.1
ENST00000550413.2 |
AMIGO2
|
adhesion molecule with Ig like domain 2 |
| chr6_-_30684744 | 7.64 |
ENST00000615892.4
|
PPP1R18
|
protein phosphatase 1 regulatory subunit 18 |
| chr9_-_120876356 | 7.61 |
ENST00000456291.1
|
PHF19
|
PHD finger protein 19 |
| chr16_-_84618067 | 7.54 |
ENST00000262428.5
|
COTL1
|
coactosin like F-actin binding protein 1 |
| chr12_+_53097656 | 7.44 |
ENST00000301464.4
|
IGFBP6
|
insulin like growth factor binding protein 6 |
| chr19_-_50952942 | 7.21 |
ENST00000594846.1
ENST00000336334.8 |
KLK5
|
kallikrein related peptidase 5 |
| chr10_+_86958557 | 7.15 |
ENST00000372017.4
ENST00000348795.8 |
SNCG
|
synuclein gamma |
| chr6_+_151239951 | 7.08 |
ENST00000402676.7
|
AKAP12
|
A-kinase anchoring protein 12 |
| chr8_+_53880867 | 6.96 |
ENST00000522225.5
|
RGS20
|
regulator of G protein signaling 20 |
| chr6_-_30687200 | 6.92 |
ENST00000399199.7
|
PPP1R18
|
protein phosphatase 1 regulatory subunit 18 |
| chr6_+_151341680 | 6.89 |
ENST00000359755.5
|
AKAP12
|
A-kinase anchoring protein 12 |
| chr11_-_66907891 | 6.85 |
ENST00000393955.6
|
PC
|
pyruvate carboxylase |
| chr15_-_74212256 | 6.77 |
ENST00000416286.7
|
STRA6
|
signaling receptor and transporter of retinol STRA6 |
| chr16_-_84618041 | 6.76 |
ENST00000564057.1
|
COTL1
|
coactosin like F-actin binding protein 1 |
| chr16_+_66603874 | 6.72 |
ENST00000563672.5
ENST00000424011.6 |
CMTM3
|
CKLF like MARVEL transmembrane domain containing 3 |
| chr3_-_13880059 | 6.65 |
ENST00000285018.5
|
WNT7A
|
Wnt family member 7A |
| chr5_-_128538230 | 6.61 |
ENST00000262464.9
|
FBN2
|
fibrillin 2 |
| chr7_+_142760398 | 6.57 |
ENST00000632998.1
|
PRSS2
|
serine protease 2 |
| chr1_-_24143112 | 6.56 |
ENST00000270800.2
|
IL22RA1
|
interleukin 22 receptor subunit alpha 1 |
| chr1_-_153549238 | 6.54 |
ENST00000368713.8
|
S100A3
|
S100 calcium binding protein A3 |
| chr11_-_125592448 | 6.53 |
ENST00000648911.1
|
FEZ1
|
fasciculation and elongation protein zeta 1 |
| chr22_+_37675629 | 6.52 |
ENST00000215909.10
|
LGALS1
|
galectin 1 |
| chr8_+_53880894 | 6.42 |
ENST00000276500.4
|
RGS20
|
regulator of G protein signaling 20 |
| chr22_+_31092447 | 6.39 |
ENST00000455608.5
|
SMTN
|
smoothelin |
| chr1_+_65525641 | 6.39 |
ENST00000344610.12
ENST00000616738.4 |
LEPR
|
leptin receptor |
| chr19_+_54415427 | 6.37 |
ENST00000301194.8
ENST00000376530.8 ENST00000445095.5 ENST00000376531.3 |
TTYH1
|
tweety family member 1 |
| chrX_-_107775951 | 6.36 |
ENST00000315660.8
ENST00000372384.6 ENST00000502650.1 ENST00000506724.1 |
TSC22D3
|
TSC22 domain family member 3 |
| chr1_+_31576485 | 6.35 |
ENST00000457433.6
ENST00000271064.12 |
TINAGL1
|
tubulointerstitial nephritis antigen like 1 |
| chr2_-_112836702 | 6.28 |
ENST00000416750.1
ENST00000263341.7 ENST00000418817.5 |
IL1B
|
interleukin 1 beta |
| chr9_+_33795551 | 6.28 |
ENST00000379405.4
|
PRSS3
|
serine protease 3 |
| chr19_-_35513641 | 6.27 |
ENST00000339686.8
ENST00000447113.6 |
DMKN
|
dermokine |
| chr19_-_9785996 | 6.24 |
ENST00000589412.5
ENST00000586814.5 |
ZNF846
|
zinc finger protein 846 |
| chr2_-_70553440 | 6.14 |
ENST00000450929.5
|
TGFA
|
transforming growth factor alpha |
| chr1_+_152985231 | 6.14 |
ENST00000368762.1
|
SPRR1A
|
small proline rich protein 1A |
| chr1_-_153549120 | 6.13 |
ENST00000368712.1
|
S100A3
|
S100 calcium binding protein A3 |
| chr7_+_142770960 | 6.08 |
ENST00000632805.1
ENST00000633969.1 ENST00000539842.6 |
PRSS2
|
serine protease 2 |
| chr14_-_104953899 | 6.08 |
ENST00000557457.1
|
AHNAK2
|
AHNAK nucleoprotein 2 |
| chr12_-_54419259 | 6.03 |
ENST00000293379.9
|
ITGA5
|
integrin subunit alpha 5 |
| chr6_+_85449584 | 6.03 |
ENST00000369651.7
|
NT5E
|
5'-nucleotidase ecto |
| chr12_-_57237090 | 6.02 |
ENST00000556732.1
|
NDUFA4L2
|
NDUFA4 mitochondrial complex associated like 2 |
| chrX_-_48470243 | 6.01 |
ENST00000429543.2
ENST00000620913.5 |
SLC38A5
|
solute carrier family 38 member 5 |
| chr19_-_51020019 | 5.97 |
ENST00000309958.7
|
KLK10
|
kallikrein related peptidase 10 |
| chr17_+_42458844 | 5.94 |
ENST00000393829.6
ENST00000537728.5 ENST00000343619.9 ENST00000264649.10 ENST00000585525.5 ENST00000544137.5 ENST00000589727.5 ENST00000587824.5 |
ATP6V0A1
|
ATPase H+ transporting V0 subunit a1 |
| chr15_-_74212219 | 5.91 |
ENST00000449139.6
|
STRA6
|
signaling receptor and transporter of retinol STRA6 |
| chr5_+_151020438 | 5.90 |
ENST00000622181.4
ENST00000614343.4 ENST00000388825.9 ENST00000521650.5 ENST00000517973.1 |
GPX3
|
glutathione peroxidase 3 |
| chr16_-_85751112 | 5.89 |
ENST00000602766.1
|
C16orf74
|
chromosome 16 open reading frame 74 |
| chr4_+_8580387 | 5.88 |
ENST00000382487.5
|
GPR78
|
G protein-coupled receptor 78 |
| chr2_+_233059838 | 5.87 |
ENST00000359570.9
|
INPP5D
|
inositol polyphosphate-5-phosphatase D |
| chr16_+_66604696 | 5.87 |
ENST00000567572.6
ENST00000564060.5 ENST00000565922.1 |
CMTM3
|
CKLF like MARVEL transmembrane domain containing 3 |
| chr19_+_44777860 | 5.86 |
ENST00000341505.4
ENST00000647358.2 |
CBLC
|
Cbl proto-oncogene C |
| chr19_-_51020154 | 5.84 |
ENST00000391805.5
ENST00000599077.1 |
KLK10
|
kallikrein related peptidase 10 |
| chr19_-_51034840 | 5.84 |
ENST00000529888.5
|
KLK12
|
kallikrein related peptidase 12 |
| chr19_-_18941184 | 5.82 |
ENST00000594794.5
ENST00000392351.8 ENST00000596482.5 |
HOMER3
|
homer scaffold protein 3 |
| chr10_-_5499544 | 5.80 |
ENST00000380332.5
|
CALML5
|
calmodulin like 5 |
| chr19_-_51034892 | 5.79 |
ENST00000319590.8
ENST00000250351.4 |
KLK12
|
kallikrein related peptidase 12 |
| chr14_-_93955577 | 5.74 |
ENST00000555507.5
|
ASB2
|
ankyrin repeat and SOCS box containing 2 |
| chr2_-_31414694 | 5.70 |
ENST00000379416.4
|
XDH
|
xanthine dehydrogenase |
| chr19_+_6531018 | 5.67 |
ENST00000245817.5
|
TNFSF9
|
TNF superfamily member 9 |
| chr12_+_4273751 | 5.67 |
ENST00000675880.1
ENST00000261254.8 |
CCND2
|
cyclin D2 |
| chr14_-_93976550 | 5.66 |
ENST00000555019.6
|
ASB2
|
ankyrin repeat and SOCS box containing 2 |
| chr19_-_51065067 | 5.65 |
ENST00000595547.5
ENST00000335422.3 ENST00000595793.6 ENST00000596955.1 |
KLK13
|
kallikrein related peptidase 13 |
| chr16_+_8712943 | 5.62 |
ENST00000561870.5
ENST00000396600.6 |
ABAT
|
4-aminobutyrate aminotransferase |
| chr6_+_85450033 | 5.60 |
ENST00000257770.8
ENST00000369646.7 |
NT5E
|
5'-nucleotidase ecto |
| chr2_-_191151568 | 5.59 |
ENST00000358470.8
ENST00000432798.1 ENST00000450994.1 |
STAT4
|
signal transducer and activator of transcription 4 |
| chr1_+_17205119 | 5.54 |
ENST00000375471.5
|
PADI1
|
peptidyl arginine deiminase 1 |
| chr21_-_26845402 | 5.54 |
ENST00000284984.8
ENST00000676955.1 |
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif 1 |
| chr16_-_85751028 | 5.46 |
ENST00000284245.9
ENST00000602914.1 |
C16orf74
|
chromosome 16 open reading frame 74 |
| chr2_+_64454145 | 5.46 |
ENST00000238875.10
|
LGALSL
|
galectin like |
| chr19_-_18940289 | 5.42 |
ENST00000542541.6
ENST00000433218.6 |
HOMER3
|
homer scaffold protein 3 |
| chr7_-_50782853 | 5.41 |
ENST00000401949.6
|
GRB10
|
growth factor receptor bound protein 10 |
| chr1_+_203682734 | 5.39 |
ENST00000341360.6
|
ATP2B4
|
ATPase plasma membrane Ca2+ transporting 4 |
| chr9_+_128882502 | 5.39 |
ENST00000259324.5
|
LRRC8A
|
leucine rich repeat containing 8 VRAC subunit A |
| chr1_-_153057504 | 5.38 |
ENST00000392653.3
|
SPRR2A
|
small proline rich protein 2A |
| chr9_+_122375286 | 5.37 |
ENST00000373698.7
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 |
| chr3_-_98901656 | 5.36 |
ENST00000326840.11
|
DCBLD2
|
discoidin, CUB and LCCL domain containing 2 |
| chr6_+_149942006 | 5.34 |
ENST00000367351.4
|
ULBP2
|
UL16 binding protein 2 |
| chr20_-_54173976 | 5.28 |
ENST00000216862.8
|
CYP24A1
|
cytochrome P450 family 24 subfamily A member 1 |
| chr20_-_23049659 | 5.27 |
ENST00000377103.3
|
THBD
|
thrombomodulin |
| chr1_-_16980607 | 5.24 |
ENST00000375535.4
|
MFAP2
|
microfibril associated protein 2 |
| chr19_-_50823778 | 5.18 |
ENST00000301420.3
|
KLK1
|
kallikrein 1 |
| chr14_-_74612226 | 5.18 |
ENST00000261978.9
|
LTBP2
|
latent transforming growth factor beta binding protein 2 |
| chr19_-_18941117 | 5.17 |
ENST00000600077.5
|
HOMER3
|
homer scaffold protein 3 |
| chr5_-_150302884 | 5.10 |
ENST00000328668.8
|
ARSI
|
arylsulfatase family member I |
| chr16_-_85750951 | 5.08 |
ENST00000602675.5
|
C16orf74
|
chromosome 16 open reading frame 74 |
| chr16_+_55479188 | 5.05 |
ENST00000219070.9
|
MMP2
|
matrix metallopeptidase 2 |
| chr2_+_227813834 | 5.05 |
ENST00000358813.5
ENST00000409189.7 |
CCL20
|
C-C motif chemokine ligand 20 |
| chr9_+_34653864 | 5.04 |
ENST00000556792.5
ENST00000318041.13 |
IL11RA
|
interleukin 11 receptor subunit alpha |
| chr2_+_113059194 | 5.03 |
ENST00000393200.7
|
IL36RN
|
interleukin 36 receptor antagonist |
| chr3_+_99638475 | 5.03 |
ENST00000452013.5
ENST00000261037.7 ENST00000652472.1 ENST00000273342.8 ENST00000621757.1 |
COL8A1
|
collagen type VIII alpha 1 chain |
| chr19_-_11578937 | 5.02 |
ENST00000592659.1
ENST00000592828.6 ENST00000218758.9 ENST00000412435.6 |
ACP5
|
acid phosphatase 5, tartrate resistant |
| chr17_+_8039106 | 4.99 |
ENST00000573359.1
|
ALOX15B
|
arachidonate 15-lipoxygenase type B |
| chr20_-_44651683 | 4.96 |
ENST00000537820.1
ENST00000372874.9 |
ADA
|
adenosine deaminase |
| chr7_-_93890160 | 4.95 |
ENST00000451238.1
|
TFPI2
|
tissue factor pathway inhibitor 2 |
| chr17_+_44004604 | 4.91 |
ENST00000293404.8
ENST00000589767.1 |
NAGS
|
N-acetylglutamate synthase |
| chr1_-_26354080 | 4.88 |
ENST00000308182.10
|
CRYBG2
|
crystallin beta-gamma domain containing 2 |
| chr6_-_150025520 | 4.82 |
ENST00000367341.6
ENST00000286380.2 |
RAET1L
|
retinoic acid early transcript 1L |
| chrX_-_48470163 | 4.80 |
ENST00000595796.5
|
SLC38A5
|
solute carrier family 38 member 5 |
| chr19_-_51009586 | 4.80 |
ENST00000594211.2
|
KLK9
|
kallikrein related peptidase 9 |
| chr12_-_124863783 | 4.75 |
ENST00000546215.5
ENST00000415380.6 ENST00000545493.1 ENST00000261693.11 ENST00000680596.1 |
SCARB1
|
scavenger receptor class B member 1 |
| chr2_-_215436061 | 4.74 |
ENST00000421182.5
ENST00000432072.6 ENST00000323926.10 ENST00000336916.8 ENST00000357867.8 ENST00000359671.5 ENST00000446046.5 ENST00000354785.11 ENST00000356005.8 ENST00000443816.5 ENST00000426059.1 |
FN1
|
fibronectin 1 |
| chr22_+_37051787 | 4.73 |
ENST00000456470.1
|
KCTD17
|
potassium channel tetramerization domain containing 17 |
| chr15_-_74203172 | 4.73 |
ENST00000616000.4
|
STRA6
|
signaling receptor and transporter of retinol STRA6 |
| chr22_-_38317380 | 4.71 |
ENST00000413574.6
|
CSNK1E
|
casein kinase 1 epsilon |
| chr12_+_56521990 | 4.66 |
ENST00000550726.5
ENST00000542360.1 |
RBMS2
|
RNA binding motif single stranded interacting protein 2 |
| chr8_-_22141851 | 4.66 |
ENST00000334530.9
ENST00000306306.8 |
REEP4
|
receptor accessory protein 4 |
| chrX_+_41333342 | 4.65 |
ENST00000629496.3
ENST00000625837.2 ENST00000626301.2 |
DDX3X
|
DEAD-box helicase 3 X-linked |
| chr17_+_7440738 | 4.65 |
ENST00000575398.5
ENST00000575082.5 |
FGF11
|
fibroblast growth factor 11 |
| chr19_+_917287 | 4.64 |
ENST00000592648.1
ENST00000234371.10 |
KISS1R
|
KISS1 receptor |
| chr7_+_101127095 | 4.60 |
ENST00000223095.5
|
SERPINE1
|
serpin family E member 1 |
| chr12_+_65824475 | 4.59 |
ENST00000403681.7
|
HMGA2
|
high mobility group AT-hook 2 |
| chr19_-_50511203 | 4.59 |
ENST00000595669.5
|
JOSD2
|
Josephin domain containing 2 |
| chr9_-_41128681 | 4.58 |
ENST00000622588.2
|
FOXD4L6
|
forkhead box D4 like 6 |
| chr1_+_150549384 | 4.56 |
ENST00000369041.9
ENST00000271643.9 |
ADAMTSL4
|
ADAMTS like 4 |
| chr17_+_4833331 | 4.56 |
ENST00000355280.11
ENST00000347992.11 |
MINK1
|
misshapen like kinase 1 |
| chr4_-_56656304 | 4.54 |
ENST00000503639.7
|
HOPX
|
HOP homeobox |
| chrX_-_107775740 | 4.54 |
ENST00000372383.9
|
TSC22D3
|
TSC22 domain family member 3 |
| chr7_-_23347704 | 4.54 |
ENST00000619562.4
|
IGF2BP3
|
insulin like growth factor 2 mRNA binding protein 3 |
| chr17_+_41812974 | 4.53 |
ENST00000321562.9
|
FKBP10
|
FKBP prolyl isomerase 10 |
| chr9_+_35673917 | 4.51 |
ENST00000617161.1
ENST00000378357.9 |
CA9
|
carbonic anhydrase 9 |
| chr9_+_122371036 | 4.51 |
ENST00000619306.5
ENST00000426608.6 ENST00000223423.8 |
PTGS1
|
prostaglandin-endoperoxide synthase 1 |
| chr11_+_124865425 | 4.51 |
ENST00000397801.6
|
ROBO3
|
roundabout guidance receptor 3 |
| chr4_-_80073465 | 4.49 |
ENST00000404191.5
|
ANTXR2
|
ANTXR cell adhesion molecule 2 |
| chr9_+_128420812 | 4.49 |
ENST00000372838.9
|
CERCAM
|
cerebral endothelial cell adhesion molecule |
| chr7_-_24757413 | 4.48 |
ENST00000645220.1
ENST00000409970.6 |
GSDME
|
gasdermin E |
| chr17_+_72121012 | 4.48 |
ENST00000245479.3
|
SOX9
|
SRY-box transcription factor 9 |
| chr15_+_90201301 | 4.48 |
ENST00000411539.6
|
SEMA4B
|
semaphorin 4B |
| chr11_+_57542641 | 4.45 |
ENST00000527972.5
ENST00000399154.3 |
SMTNL1
|
smoothelin like 1 |
| chr1_-_39691393 | 4.45 |
ENST00000372844.8
|
HPCAL4
|
hippocalcin like 4 |
| chr9_-_21305313 | 4.43 |
ENST00000610521.2
|
IFNA5
|
interferon alpha 5 |
| chr17_+_42552920 | 4.41 |
ENST00000585807.6
ENST00000225929.5 |
HSD17B1
|
hydroxysteroid 17-beta dehydrogenase 1 |
| chr22_+_30396991 | 4.41 |
ENST00000617837.4
ENST00000615189.5 ENST00000405717.7 ENST00000402592.7 |
SEC14L2
|
SEC14 like lipid binding 2 |
| chr8_-_10839818 | 4.41 |
ENST00000554914.1
|
PINX1
|
PIN2 (TERF1) interacting telomerase inhibitor 1 |
| chr11_-_123195208 | 4.41 |
ENST00000448775.4
|
CLMP
|
CXADR like membrane protein |
| chr5_-_151686908 | 4.40 |
ENST00000231061.9
|
SPARC
|
secreted protein acidic and cysteine rich |
| chr12_-_124863902 | 4.39 |
ENST00000339570.9
ENST00000680556.1 |
SCARB1
|
scavenger receptor class B member 1 |
| chr12_+_53098846 | 4.38 |
ENST00000650247.1
ENST00000549628.1 |
IGFBP6
|
insulin like growth factor binding protein 6 |
| chr20_-_57710001 | 4.38 |
ENST00000341744.8
|
PMEPA1
|
prostate transmembrane protein, androgen induced 1 |
| chr9_-_112333562 | 4.37 |
ENST00000343327.6
|
PTBP3
|
polypyrimidine tract binding protein 3 |
| chr10_+_73911104 | 4.37 |
ENST00000446342.5
ENST00000372764.4 |
PLAU
|
plasminogen activator, urokinase |
| chr11_+_13668702 | 4.31 |
ENST00000532701.1
|
FAR1
|
fatty acyl-CoA reductase 1 |
| chr9_-_118417 | 4.30 |
ENST00000382500.4
|
FOXD4
|
forkhead box D4 |
| chr10_-_99235783 | 4.29 |
ENST00000370546.5
ENST00000614306.1 |
HPSE2
|
heparanase 2 (inactive) |
| chr19_-_55147319 | 4.27 |
ENST00000593046.5
|
TNNT1
|
troponin T1, slow skeletal type |
| chr1_-_153094521 | 4.27 |
ENST00000368750.8
|
SPRR2E
|
small proline rich protein 2E |
| chr1_+_152514474 | 4.27 |
ENST00000368790.4
|
CRCT1
|
cysteine rich C-terminal 1 |
| chr4_-_98658582 | 4.27 |
ENST00000305798.8
|
TSPAN5
|
tetraspanin 5 |
| chr8_+_123182635 | 4.26 |
ENST00000276699.10
ENST00000522648.5 |
FAM83A
|
family with sequence similarity 83 member A |
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 10.4 | 31.3 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 9.7 | 58.1 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
| 5.8 | 86.7 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 4.9 | 14.7 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 4.7 | 14.1 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 4.3 | 17.4 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
| 4.2 | 79.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 4.1 | 8.3 | GO:0046136 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
| 4.0 | 24.1 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 3.9 | 11.8 | GO:1903249 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
| 3.5 | 14.1 | GO:1904450 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 3.4 | 13.6 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
| 3.3 | 10.0 | GO:0042938 | dipeptide transport(GO:0042938) |
| 3.3 | 29.9 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 3.3 | 16.5 | GO:0009099 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 3.1 | 9.3 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 3.1 | 9.2 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 3.0 | 12.2 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 3.0 | 8.9 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 2.9 | 8.8 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 2.8 | 11.2 | GO:0042377 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 2.8 | 5.6 | GO:2000309 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) |
| 2.7 | 10.9 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 2.7 | 10.8 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
| 2.6 | 15.8 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 2.5 | 7.4 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
| 2.5 | 7.4 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 2.4 | 12.0 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
| 2.4 | 4.7 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 2.3 | 6.9 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
| 2.2 | 9.0 | GO:0003131 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
| 2.2 | 20.1 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 2.2 | 6.5 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 2.2 | 6.5 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 2.1 | 8.5 | GO:0061552 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 2.1 | 6.3 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 2.0 | 24.5 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 2.0 | 12.2 | GO:0051012 | microtubule sliding(GO:0051012) |
| 2.0 | 7.9 | GO:0003409 | optic cup structural organization(GO:0003409) |
| 2.0 | 5.9 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 1.9 | 9.7 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 1.9 | 7.7 | GO:0090096 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 1.9 | 3.8 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 1.9 | 22.9 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 1.9 | 7.6 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 1.9 | 1.9 | GO:0032912 | negative regulation of transforming growth factor beta2 production(GO:0032912) |
| 1.9 | 5.6 | GO:0060516 | primary prostatic bud elongation(GO:0060516) |
| 1.8 | 1.8 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
| 1.8 | 8.9 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 1.8 | 7.1 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 1.8 | 7.1 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 1.8 | 1.8 | GO:0070101 | positive regulation of chemokine-mediated signaling pathway(GO:0070101) |
| 1.7 | 7.0 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 1.7 | 10.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 1.7 | 8.6 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
| 1.7 | 10.3 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 1.7 | 8.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 1.7 | 5.0 | GO:0048817 | negative regulation of hair follicle maturation(GO:0048817) |
| 1.7 | 5.0 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
| 1.7 | 3.3 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 1.7 | 6.6 | GO:1990834 | response to odorant(GO:1990834) |
| 1.6 | 8.2 | GO:0030035 | microspike assembly(GO:0030035) |
| 1.6 | 4.9 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 1.6 | 6.5 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 1.6 | 1.6 | GO:0010868 | negative regulation of triglyceride biosynthetic process(GO:0010868) |
| 1.6 | 6.5 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 1.6 | 4.8 | GO:0060032 | notochord regression(GO:0060032) |
| 1.6 | 6.4 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 1.6 | 4.8 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 1.6 | 1.6 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
| 1.6 | 4.7 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 1.6 | 7.8 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 1.5 | 4.6 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 1.5 | 7.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 1.5 | 4.6 | GO:0046108 | uridine metabolic process(GO:0046108) |
| 1.5 | 1.5 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
| 1.5 | 1.5 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 1.5 | 3.0 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
| 1.5 | 25.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 1.5 | 4.4 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 1.5 | 11.7 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 1.5 | 11.7 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 1.5 | 5.8 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 1.5 | 7.3 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 1.4 | 5.8 | GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 1.4 | 1.4 | GO:1903921 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
| 1.4 | 4.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 1.4 | 7.1 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 1.4 | 14.1 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
| 1.4 | 1.4 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) |
| 1.4 | 1.4 | GO:0006565 | L-serine catabolic process(GO:0006565) |
| 1.4 | 23.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 1.4 | 4.2 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
| 1.4 | 8.4 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 1.4 | 8.4 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 1.4 | 1.4 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 1.4 | 12.5 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
| 1.4 | 8.2 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 1.4 | 4.1 | GO:0043465 | fermentation(GO:0006113) regulation of fermentation(GO:0043465) |
| 1.4 | 8.2 | GO:0007296 | vitellogenesis(GO:0007296) |
| 1.4 | 15.0 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 1.4 | 5.4 | GO:0042335 | cuticle development(GO:0042335) |
| 1.4 | 5.4 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 1.4 | 1.4 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
| 1.3 | 5.4 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 1.3 | 3.9 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 1.3 | 3.9 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
| 1.3 | 12.9 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 1.3 | 3.9 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
| 1.3 | 10.3 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 1.3 | 3.8 | GO:0045360 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 1.3 | 5.1 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
| 1.3 | 11.5 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 1.3 | 6.4 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 1.3 | 3.8 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
| 1.3 | 35.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 1.3 | 8.8 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
| 1.2 | 6.2 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 1.2 | 5.0 | GO:0048627 | myoblast development(GO:0048627) |
| 1.2 | 1.2 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 1.2 | 4.9 | GO:0070982 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 1.2 | 2.4 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 1.2 | 3.6 | GO:1905204 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
| 1.2 | 3.6 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 1.2 | 32.6 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 1.2 | 4.8 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 1.2 | 3.6 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
| 1.2 | 11.9 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 1.2 | 3.5 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 1.2 | 2.4 | GO:0051885 | positive regulation of anagen(GO:0051885) |
| 1.2 | 3.5 | GO:0000494 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 1.2 | 19.8 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 1.2 | 2.3 | GO:0071878 | negative regulation of adrenergic receptor signaling pathway(GO:0071878) |
| 1.1 | 6.9 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
| 1.1 | 10.3 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 1.1 | 3.4 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 1.1 | 2.3 | GO:0021622 | oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 1.1 | 1.1 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
| 1.1 | 4.5 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 1.1 | 1.1 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 1.1 | 6.5 | GO:0021553 | olfactory nerve development(GO:0021553) |
| 1.1 | 11.9 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 1.1 | 2.2 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 1.1 | 4.3 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
| 1.1 | 14.0 | GO:0038129 | ERBB3 signaling pathway(GO:0038129) |
| 1.1 | 5.4 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
| 1.1 | 7.5 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
| 1.1 | 5.3 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 1.1 | 6.4 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 1.1 | 1.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 1.1 | 17.0 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 1.1 | 2.1 | GO:0051695 | actin filament uncapping(GO:0051695) |
| 1.1 | 12.7 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 1.1 | 5.3 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
| 1.0 | 5.2 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 1.0 | 1.0 | GO:0060157 | urinary bladder development(GO:0060157) |
| 1.0 | 6.2 | GO:0019343 | cysteine biosynthetic process from serine(GO:0006535) cysteine biosynthetic process via cystathionine(GO:0019343) |
| 1.0 | 2.1 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
| 1.0 | 3.1 | GO:0032455 | nerve growth factor processing(GO:0032455) |
| 1.0 | 6.1 | GO:0032252 | secretory granule localization(GO:0032252) |
| 1.0 | 7.1 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 1.0 | 4.0 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 1.0 | 9.0 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 1.0 | 1.0 | GO:0003169 | coronary vein morphogenesis(GO:0003169) |
| 1.0 | 11.9 | GO:0070141 | response to UV-A(GO:0070141) |
| 1.0 | 4.0 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 1.0 | 4.0 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 1.0 | 6.0 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
| 1.0 | 4.0 | GO:0090472 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 1.0 | 3.0 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 1.0 | 19.8 | GO:0001845 | phagolysosome assembly(GO:0001845) |
| 1.0 | 6.9 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 1.0 | 7.9 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 1.0 | 12.8 | GO:0001660 | fever generation(GO:0001660) |
| 1.0 | 6.9 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 1.0 | 6.9 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 1.0 | 3.9 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 1.0 | 13.6 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 1.0 | 1.9 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
| 1.0 | 2.9 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 1.0 | 2.9 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
| 1.0 | 2.9 | GO:0014028 | notochord formation(GO:0014028) |
| 1.0 | 1.9 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
| 1.0 | 3.8 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 1.0 | 5.7 | GO:0044351 | macropinocytosis(GO:0044351) |
| 1.0 | 2.9 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
| 0.9 | 0.9 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 0.9 | 0.9 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
| 0.9 | 0.9 | GO:0035931 | mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
| 0.9 | 7.5 | GO:0072221 | distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) |
| 0.9 | 6.6 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 0.9 | 1.9 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
| 0.9 | 0.9 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
| 0.9 | 0.9 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.9 | 1.8 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) |
| 0.9 | 2.7 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.9 | 4.5 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.9 | 2.7 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
| 0.9 | 14.3 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.9 | 3.6 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
| 0.9 | 3.6 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
| 0.9 | 0.9 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 0.9 | 13.3 | GO:0015816 | glycine transport(GO:0015816) |
| 0.9 | 15.0 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
| 0.9 | 6.1 | GO:0060694 | regulation of cholesterol transporter activity(GO:0060694) |
| 0.9 | 3.5 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.9 | 5.3 | GO:0060356 | leucine import(GO:0060356) |
| 0.9 | 2.6 | GO:0060426 | lung vasculature development(GO:0060426) |
| 0.9 | 3.5 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.9 | 5.2 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.9 | 9.6 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
| 0.9 | 4.4 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.9 | 1.7 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
| 0.9 | 2.6 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 0.9 | 1.7 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.9 | 1.7 | GO:0002543 | activation of blood coagulation via clotting cascade(GO:0002543) |
| 0.9 | 2.6 | GO:0033037 | polysaccharide localization(GO:0033037) |
| 0.9 | 7.7 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
| 0.9 | 9.4 | GO:0009629 | response to gravity(GO:0009629) |
| 0.9 | 3.4 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.8 | 3.4 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
| 0.8 | 1.7 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.8 | 0.8 | GO:0048242 | regulation of epinephrine secretion(GO:0014060) epinephrine secretion(GO:0048242) |
| 0.8 | 3.4 | GO:0030070 | insulin processing(GO:0030070) |
| 0.8 | 4.2 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 0.8 | 0.8 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
| 0.8 | 6.7 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.8 | 3.3 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.8 | 1.7 | GO:0098758 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.8 | 2.5 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
| 0.8 | 15.7 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.8 | 15.6 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.8 | 0.8 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.8 | 13.9 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.8 | 7.3 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.8 | 8.9 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.8 | 4.9 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of lung blood pressure(GO:0061767) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.8 | 5.7 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
| 0.8 | 3.2 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.8 | 2.4 | GO:0005999 | xylulose biosynthetic process(GO:0005999) |
| 0.8 | 3.2 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.8 | 0.8 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.8 | 4.8 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.8 | 0.8 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.8 | 1.6 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.8 | 5.6 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.8 | 1.6 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.8 | 1.6 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.8 | 1.6 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 0.8 | 4.0 | GO:0015820 | leucine transport(GO:0015820) |
| 0.8 | 2.4 | GO:0051039 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 0.8 | 3.9 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.8 | 15.7 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.8 | 4.7 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 0.8 | 8.6 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.8 | 1.6 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
| 0.8 | 10.9 | GO:0071481 | cellular response to X-ray(GO:0071481) |
| 0.8 | 3.9 | GO:0042853 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.8 | 2.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.8 | 2.3 | GO:0010193 | response to ozone(GO:0010193) |
| 0.8 | 9.2 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.8 | 3.8 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
| 0.8 | 3.1 | GO:0003164 | His-Purkinje system development(GO:0003164) |
| 0.8 | 11.5 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.8 | 3.0 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
| 0.8 | 0.8 | GO:1904582 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
| 0.8 | 5.3 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.8 | 3.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.8 | 6.1 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.8 | 0.8 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
| 0.8 | 3.8 | GO:0033058 | directional locomotion(GO:0033058) |
| 0.8 | 9.0 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.8 | 15.1 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.8 | 2.3 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
| 0.7 | 3.0 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.7 | 0.7 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.7 | 2.2 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
| 0.7 | 3.0 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.7 | 3.0 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.7 | 0.7 | GO:0071306 | cellular response to vitamin E(GO:0071306) |
| 0.7 | 3.0 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.7 | 7.5 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.7 | 90.3 | GO:0070268 | cornification(GO:0070268) |
| 0.7 | 4.5 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
| 0.7 | 2.2 | GO:0071962 | mitotic sister chromatid cohesion, centromeric(GO:0071962) |
| 0.7 | 3.7 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.7 | 1.5 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
| 0.7 | 5.2 | GO:0060346 | bone trabecula formation(GO:0060346) |
| 0.7 | 3.0 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.7 | 4.4 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 0.7 | 4.4 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.7 | 2.2 | GO:0038158 | granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
| 0.7 | 2.2 | GO:0070352 | positive regulation of white fat cell proliferation(GO:0070352) |
| 0.7 | 10.2 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.7 | 1.5 | GO:2000296 | regulation of hydrogen peroxide catabolic process(GO:2000295) negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 0.7 | 1.5 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
| 0.7 | 3.6 | GO:0071725 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
| 0.7 | 2.9 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.7 | 4.3 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
| 0.7 | 1.4 | GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) |
| 0.7 | 10.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.7 | 1.4 | GO:0097107 | postsynaptic density assembly(GO:0097107) gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.7 | 2.1 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.7 | 1.4 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.7 | 0.7 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
| 0.7 | 4.3 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
| 0.7 | 1.4 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 0.7 | 2.1 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
| 0.7 | 7.0 | GO:0071476 | cellular hypotonic response(GO:0071476) |
| 0.7 | 2.8 | GO:0001927 | exocyst assembly(GO:0001927) |
| 0.7 | 2.1 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.7 | 0.7 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.7 | 6.9 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
| 0.7 | 9.7 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.7 | 0.7 | GO:0040009 | regulation of growth rate(GO:0040009) |
| 0.7 | 1.4 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
| 0.7 | 6.8 | GO:0010819 | regulation of T cell chemotaxis(GO:0010819) |
| 0.7 | 1.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.7 | 19.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.7 | 2.0 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.7 | 4.0 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 0.7 | 1.3 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.7 | 1.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.7 | 2.0 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.7 | 4.0 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.7 | 1.3 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.7 | 6.7 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.7 | 2.7 | GO:0035627 | ceramide transport(GO:0035627) |
| 0.7 | 2.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.7 | 0.7 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
| 0.7 | 29.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.7 | 5.3 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 0.7 | 2.0 | GO:0007343 | egg activation(GO:0007343) |
| 0.7 | 3.3 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 0.7 | 5.9 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.7 | 2.6 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.7 | 2.0 | GO:0035290 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 0.7 | 2.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.7 | 5.9 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.7 | 2.6 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
| 0.7 | 11.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.7 | 2.0 | GO:0097187 | dentinogenesis(GO:0097187) |
| 0.7 | 2.0 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
| 0.7 | 11.1 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.7 | 2.0 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.6 | 1.9 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
| 0.6 | 6.5 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.6 | 1.9 | GO:1990654 | regulation of extrathymic T cell differentiation(GO:0033082) sebum secreting cell proliferation(GO:1990654) |
| 0.6 | 5.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.6 | 2.6 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.6 | 1.9 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.6 | 1.9 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
| 0.6 | 5.8 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.6 | 4.5 | GO:0030421 | defecation(GO:0030421) |
| 0.6 | 3.2 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.6 | 0.6 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
| 0.6 | 2.6 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
| 0.6 | 1.3 | GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus(GO:0002876) |
| 0.6 | 0.6 | GO:0015803 | branched-chain amino acid transport(GO:0015803) |
| 0.6 | 1.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.6 | 1.9 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.6 | 7.6 | GO:0046958 | nonassociative learning(GO:0046958) |
| 0.6 | 1.9 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 0.6 | 6.9 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.6 | 1.3 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 0.6 | 2.5 | GO:1905205 | regulation of connective tissue replacement(GO:1905203) positive regulation of connective tissue replacement(GO:1905205) |
| 0.6 | 4.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.6 | 1.9 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.6 | 2.5 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.6 | 4.3 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.6 | 1.8 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.6 | 1.8 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.6 | 5.5 | GO:0032364 | oxygen homeostasis(GO:0032364) |
| 0.6 | 7.9 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
| 0.6 | 0.6 | GO:0072003 | kidney rudiment formation(GO:0072003) |
| 0.6 | 3.0 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.6 | 0.6 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
| 0.6 | 4.8 | GO:0015705 | iodide transport(GO:0015705) |
| 0.6 | 0.6 | GO:0016045 | detection of bacterium(GO:0016045) |
| 0.6 | 1.8 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.6 | 1.8 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.6 | 11.9 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.6 | 42.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.6 | 1.8 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.6 | 1.8 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.6 | 7.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.6 | 8.9 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.6 | 4.7 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.6 | 3.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.6 | 6.5 | GO:0030903 | notochord development(GO:0030903) |
| 0.6 | 0.6 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.6 | 5.3 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
| 0.6 | 1.8 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.6 | 7.0 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.6 | 7.6 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 0.6 | 0.6 | GO:0031335 | regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
| 0.6 | 1.2 | GO:1905154 | negative regulation of eosinophil activation(GO:1902567) negative regulation of membrane invagination(GO:1905154) negative regulation of eosinophil migration(GO:2000417) |
| 0.6 | 9.3 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.6 | 5.8 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.6 | 1.7 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
| 0.6 | 0.6 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.6 | 11.0 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.6 | 9.3 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.6 | 0.6 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
| 0.6 | 0.6 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
| 0.6 | 1.2 | GO:0071314 | cellular response to cocaine(GO:0071314) |
| 0.6 | 2.3 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.6 | 8.0 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.6 | 6.9 | GO:0090009 | primitive streak formation(GO:0090009) |
| 0.6 | 0.6 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
| 0.6 | 1.1 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.6 | 2.8 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.6 | 2.3 | GO:1904528 | positive regulation of microtubule binding(GO:1904528) |
| 0.6 | 3.4 | GO:2000852 | regulation of corticosterone secretion(GO:2000852) |
| 0.6 | 9.6 | GO:1903286 | regulation of potassium ion import(GO:1903286) |
| 0.6 | 0.6 | GO:0051414 | response to cortisol(GO:0051414) |
| 0.6 | 1.7 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.6 | 2.8 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
| 0.6 | 1.1 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
| 0.5 | 3.8 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.5 | 1.6 | GO:0044771 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.5 | 1.6 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.5 | 1.6 | GO:2001151 | negative regulation of glycogen (starch) synthase activity(GO:2000466) regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.5 | 1.1 | GO:1904640 | response to methionine(GO:1904640) |
| 0.5 | 2.2 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.5 | 0.5 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
| 0.5 | 4.4 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.5 | 2.7 | GO:0071895 | odontoblast differentiation(GO:0071895) |
| 0.5 | 5.4 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 0.5 | 1.6 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.5 | 0.5 | GO:0071373 | cellular response to luteinizing hormone stimulus(GO:0071373) |
| 0.5 | 2.2 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
| 0.5 | 8.6 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.5 | 9.1 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.5 | 3.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.5 | 13.4 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.5 | 3.7 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.5 | 2.1 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.5 | 1.6 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.5 | 9.1 | GO:0002544 | chronic inflammatory response(GO:0002544) |
| 0.5 | 3.7 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.5 | 2.6 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.5 | 1.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.5 | 3.2 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
| 0.5 | 0.5 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
| 0.5 | 3.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.5 | 1.6 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.5 | 1.6 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.5 | 0.5 | GO:0005989 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
| 0.5 | 1.6 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 0.5 | 1.0 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
| 0.5 | 1.6 | GO:1901073 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 0.5 | 1.6 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.5 | 2.6 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.5 | 11.9 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.5 | 0.5 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
| 0.5 | 0.5 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.5 | 1.5 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 0.5 | 0.5 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.5 | 1.0 | GO:2001186 | negative regulation of CD8-positive, alpha-beta T cell activation(GO:2001186) |
| 0.5 | 3.1 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
| 0.5 | 1.5 | GO:0021763 | subthalamic nucleus development(GO:0021763) prolactin secreting cell differentiation(GO:0060127) superior vena cava morphogenesis(GO:0060578) |
| 0.5 | 3.1 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.5 | 1.5 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
| 0.5 | 1.5 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.5 | 10.2 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.5 | 1.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.5 | 1.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.5 | 1.0 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.5 | 16.1 | GO:0097435 | fibril organization(GO:0097435) |
| 0.5 | 4.0 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.5 | 2.5 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
| 0.5 | 4.0 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
| 0.5 | 9.9 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.5 | 3.5 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
| 0.5 | 1.0 | GO:0002884 | negative regulation of type IV hypersensitivity(GO:0001808) negative regulation of hypersensitivity(GO:0002884) |
| 0.5 | 0.5 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
| 0.5 | 1.0 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
| 0.5 | 1.5 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.5 | 1.5 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.5 | 0.5 | GO:0072289 | metanephric nephron tubule formation(GO:0072289) |
| 0.5 | 5.4 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.5 | 6.8 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.5 | 1.5 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 0.5 | 1.5 | GO:0085032 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.5 | 1.9 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.5 | 2.9 | GO:0097319 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.5 | 3.4 | GO:0060068 | vagina development(GO:0060068) |
| 0.5 | 2.4 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.5 | 0.5 | GO:0086091 | regulation of heart rate by cardiac conduction(GO:0086091) |
| 0.5 | 3.4 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.5 | 1.9 | GO:0046833 | positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
| 0.5 | 1.4 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.5 | 1.0 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
| 0.5 | 4.3 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.5 | 2.4 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
| 0.5 | 1.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.5 | 1.4 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.5 | 1.4 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.5 | 5.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.5 | 2.8 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.5 | 1.4 | GO:0030047 | actin modification(GO:0030047) |
| 0.5 | 0.5 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.5 | 1.4 | GO:0022012 | subpallium cell proliferation in forebrain(GO:0022012) lateral ganglionic eminence cell proliferation(GO:0022018) lambdoid suture morphogenesis(GO:0060366) sagittal suture morphogenesis(GO:0060367) anterior semicircular canal development(GO:0060873) lateral semicircular canal development(GO:0060875) |
| 0.5 | 6.6 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
| 0.5 | 2.8 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
| 0.5 | 5.1 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.5 | 22.0 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.5 | 2.8 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.5 | 1.4 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.5 | 2.3 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.5 | 1.4 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.5 | 3.3 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 0.5 | 0.9 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
| 0.5 | 1.4 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.5 | 0.9 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
| 0.5 | 1.4 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
| 0.5 | 2.3 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.5 | 1.4 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.5 | 1.4 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.5 | 0.9 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
| 0.5 | 1.4 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
| 0.5 | 1.8 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.5 | 0.9 | GO:0051665 | membrane raft localization(GO:0051665) |
| 0.5 | 4.1 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.5 | 6.9 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.5 | 1.4 | GO:0072308 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
| 0.5 | 2.7 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.5 | 2.3 | GO:0003383 | apical constriction(GO:0003383) |
| 0.5 | 1.4 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.5 | 0.9 | GO:0052510 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.5 | 2.7 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 0.5 | 1.4 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
| 0.5 | 3.6 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.5 | 5.0 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.5 | 1.8 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.5 | 1.8 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.5 | 2.7 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.4 | 0.4 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.4 | 2.2 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.4 | 0.4 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.4 | 3.6 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.4 | 4.4 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 0.4 | 7.1 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 0.4 | 1.3 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.4 | 3.5 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.4 | 1.3 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.4 | 2.6 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 0.4 | 3.1 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.4 | 0.4 | GO:2000193 | positive regulation of fatty acid transport(GO:2000193) |
| 0.4 | 3.1 | GO:0000050 | urea cycle(GO:0000050) |
| 0.4 | 1.8 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.4 | 7.5 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.4 | 0.4 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.4 | 2.2 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.4 | 3.1 | GO:0046618 | drug export(GO:0046618) |
| 0.4 | 2.6 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.4 | 1.7 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 0.4 | 0.4 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
| 0.4 | 3.4 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.4 | 3.9 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.4 | 2.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
| 0.4 | 1.3 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.4 | 1.3 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.4 | 3.4 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
| 0.4 | 0.4 | GO:0009826 | unidimensional cell growth(GO:0009826) |
| 0.4 | 0.8 | GO:0009750 | response to fructose(GO:0009750) |
| 0.4 | 10.6 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.4 | 2.5 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.4 | 1.3 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.4 | 3.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.4 | 5.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.4 | 1.7 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
| 0.4 | 2.5 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.4 | 1.7 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
| 0.4 | 1.3 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 0.4 | 1.3 | GO:0035655 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.4 | 0.4 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.4 | 4.6 | GO:1902661 | positive regulation of glucose mediated signaling pathway(GO:1902661) |
| 0.4 | 0.4 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.4 | 1.3 | GO:0018011 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.4 | 3.8 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.4 | 0.8 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.4 | 2.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
| 0.4 | 0.4 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.4 | 1.2 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.4 | 1.2 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
| 0.4 | 8.6 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.4 | 2.5 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.4 | 1.2 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.4 | 1.6 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
| 0.4 | 2.4 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
| 0.4 | 1.6 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.4 | 0.8 | GO:0002580 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
| 0.4 | 1.2 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.4 | 12.0 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
| 0.4 | 19.2 | GO:1901998 | toxin transport(GO:1901998) |
| 0.4 | 0.8 | GO:0033700 | phospholipid efflux(GO:0033700) |
| 0.4 | 2.4 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.4 | 0.8 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.4 | 0.4 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.4 | 1.2 | GO:0072428 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.4 | 1.6 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.4 | 0.4 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
| 0.4 | 1.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.4 | 4.8 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.4 | 2.0 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 0.4 | 0.4 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
| 0.4 | 0.8 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
| 0.4 | 2.0 | GO:0014062 | regulation of serotonin secretion(GO:0014062) |
| 0.4 | 3.9 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.4 | 0.8 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.4 | 0.8 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) |
| 0.4 | 2.3 | GO:0097167 | circadian regulation of translation(GO:0097167) |
| 0.4 | 1.6 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.4 | 1.2 | GO:0021578 | hindbrain maturation(GO:0021578) pons maturation(GO:0021586) central nervous system maturation(GO:0021626) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.4 | 1.6 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.4 | 1.6 | GO:0021612 | facial nerve structural organization(GO:0021612) |
| 0.4 | 2.3 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
| 0.4 | 1.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.4 | 1.6 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.4 | 0.8 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 0.4 | 3.9 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.4 | 1.9 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.4 | 2.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.4 | 0.8 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.4 | 1.5 | GO:1904179 | regulation of adipose tissue development(GO:1904177) positive regulation of adipose tissue development(GO:1904179) |
| 0.4 | 11.8 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
| 0.4 | 1.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.4 | 2.3 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.4 | 1.5 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.4 | 5.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.4 | 5.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.4 | 0.8 | GO:0046016 | positive regulation of transcription by glucose(GO:0046016) |
| 0.4 | 1.5 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 0.4 | 3.0 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.4 | 1.1 | GO:0070836 | caveola assembly(GO:0070836) |
| 0.4 | 1.1 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.4 | 1.1 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.4 | 1.5 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
| 0.4 | 1.5 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.4 | 1.5 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.4 | 3.8 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.4 | 1.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.4 | 0.4 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.4 | 1.5 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
| 0.4 | 0.4 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.4 | 15.0 | GO:0006735 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.4 | 1.5 | GO:0032954 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.4 | 0.4 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.4 | 2.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.4 | 0.4 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) |
| 0.4 | 2.6 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.4 | 1.5 | GO:0072262 | metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
| 0.4 | 0.7 | GO:0051934 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.4 | 0.7 | GO:1902959 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) regulation of aspartic-type peptidase activity(GO:1905245) |
| 0.4 | 0.7 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.4 | 1.5 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.4 | 0.7 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.4 | 1.1 | GO:0015855 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.4 | 1.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.4 | 2.9 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.4 | 8.8 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.4 | 1.1 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
| 0.4 | 0.4 | GO:0044256 | multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) |
| 0.4 | 4.8 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.4 | 0.4 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.4 | 2.9 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.4 | 0.7 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.4 | 0.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.4 | 1.1 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.4 | 2.2 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.4 | 1.8 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.4 | 2.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.4 | 3.6 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
| 0.4 | 5.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.4 | 1.1 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
| 0.4 | 5.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.4 | 0.7 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.4 | 2.9 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 0.4 | 1.4 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
| 0.4 | 14.0 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.4 | 1.1 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) |
| 0.4 | 2.5 | GO:0051546 | keratinocyte migration(GO:0051546) |
| 0.4 | 0.4 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
| 0.4 | 0.7 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
| 0.4 | 0.4 | GO:0060264 | respiratory burst involved in inflammatory response(GO:0002536) regulation of respiratory burst involved in inflammatory response(GO:0060264) negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
| 0.4 | 1.4 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.4 | 3.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.4 | 1.8 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.4 | 1.8 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.4 | 1.1 | GO:2000662 | interleukin-5 secretion(GO:0072603) regulation of interleukin-5 secretion(GO:2000662) |
| 0.4 | 1.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
| 0.4 | 3.9 | GO:0015074 | DNA integration(GO:0015074) |
| 0.4 | 0.4 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
| 0.4 | 0.7 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
| 0.3 | 0.3 | GO:0035977 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
| 0.3 | 0.7 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 0.3 | 1.0 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.3 | 1.7 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
| 0.3 | 0.7 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
| 0.3 | 0.3 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
| 0.3 | 0.3 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
| 0.3 | 0.7 | GO:0003192 | mitral valve formation(GO:0003192) |
| 0.3 | 2.7 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.3 | 1.4 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.3 | 0.7 | GO:0048241 | epinephrine transport(GO:0048241) |
| 0.3 | 1.7 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.3 | 5.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.3 | 1.0 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 0.3 | 1.4 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.3 | 4.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.3 | 1.0 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.3 | 1.0 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
| 0.3 | 1.4 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.3 | 0.3 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.3 | 0.3 | GO:0030878 | thyroid gland development(GO:0030878) |
| 0.3 | 1.0 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.3 | 4.4 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 0.3 | 2.0 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.3 | 1.0 | GO:0060290 | transdifferentiation(GO:0060290) |
| 0.3 | 1.7 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
| 0.3 | 0.3 | GO:0051714 | positive regulation of cytolysis in other organism(GO:0051714) |
| 0.3 | 1.3 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
| 0.3 | 0.3 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
| 0.3 | 0.3 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.3 | 4.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.3 | 0.7 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
| 0.3 | 0.3 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
| 0.3 | 0.3 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.3 | 1.6 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.3 | 1.3 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.3 | 3.6 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.3 | 0.3 | GO:0006562 | proline catabolic process(GO:0006562) |
| 0.3 | 1.3 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.3 | 0.7 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 0.3 | 2.0 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.3 | 2.9 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.3 | 1.0 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.3 | 3.9 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.3 | 1.0 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
| 0.3 | 0.3 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.3 | 2.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.3 | 0.6 | GO:0015879 | carnitine transport(GO:0015879) |
| 0.3 | 0.3 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
| 0.3 | 2.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.3 | 1.0 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 0.3 | 1.0 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.3 | 0.3 | GO:0042363 | fat-soluble vitamin catabolic process(GO:0042363) |
| 0.3 | 1.6 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.3 | 0.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.3 | 18.8 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.3 | 1.6 | GO:0001964 | startle response(GO:0001964) |
| 0.3 | 3.8 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
| 0.3 | 3.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.3 | 1.3 | GO:1903936 | cellular response to sodium arsenite(GO:1903936) |
| 0.3 | 0.3 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.3 | 6.6 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.3 | 2.2 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.3 | 1.9 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 0.3 | 2.8 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.3 | 0.3 | GO:0090134 | mesendoderm migration(GO:0090133) cell migration involved in mesendoderm migration(GO:0090134) |
| 0.3 | 0.3 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
| 0.3 | 2.8 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
| 0.3 | 0.6 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.3 | 0.9 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
| 0.3 | 0.9 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.3 | 6.7 | GO:0048265 | response to pain(GO:0048265) |
| 0.3 | 0.9 | GO:0097178 | ruffle assembly(GO:0097178) |
| 0.3 | 9.2 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 0.3 | 0.9 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 0.3 | 4.6 | GO:0045072 | regulation of interferon-gamma biosynthetic process(GO:0045072) |
| 0.3 | 6.7 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.3 | 2.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.3 | 0.9 | GO:1990910 | response to hypobaric hypoxia(GO:1990910) |
| 0.3 | 1.2 | GO:0015824 | proline transport(GO:0015824) proline transmembrane transport(GO:0035524) |
| 0.3 | 11.2 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
| 0.3 | 0.9 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 0.3 | 1.5 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
| 0.3 | 0.3 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.3 | 0.3 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
| 0.3 | 0.3 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
| 0.3 | 0.9 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.3 | 0.9 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.3 | 1.5 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.3 | 0.9 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.3 | 0.6 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.3 | 3.0 | GO:1902743 | regulation of lamellipodium organization(GO:1902743) |
| 0.3 | 1.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.3 | 2.4 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.3 | 1.5 | GO:0002335 | mature B cell differentiation(GO:0002335) |
| 0.3 | 0.6 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
| 0.3 | 0.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.3 | 2.9 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.3 | 0.3 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.3 | 2.6 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.3 | 2.9 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 0.3 | 0.9 | GO:1903576 | response to L-arginine(GO:1903576) |
| 0.3 | 4.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.3 | 0.9 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 0.3 | 0.3 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.3 | 1.4 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
| 0.3 | 1.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
| 0.3 | 2.9 | GO:0001967 | suckling behavior(GO:0001967) |
| 0.3 | 0.3 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.3 | 1.4 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.3 | 0.9 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
| 0.3 | 0.3 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 0.3 | 2.0 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
| 0.3 | 1.1 | GO:1903182 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.3 | 2.8 | GO:0048535 | lymph node development(GO:0048535) |
| 0.3 | 1.4 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
| 0.3 | 2.0 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.3 | 0.3 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.3 | 0.3 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
| 0.3 | 0.6 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
| 0.3 | 1.4 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
| 0.3 | 1.7 | GO:0034227 | tRNA thio-modification(GO:0034227) |
| 0.3 | 0.6 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.3 | 16.4 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.3 | 0.8 | GO:0097503 | sialylation(GO:0097503) |
| 0.3 | 0.6 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.3 | 3.3 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.3 | 5.5 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.3 | 1.6 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.3 | 0.3 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 0.3 | 0.3 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.3 | 6.0 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.3 | 0.5 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 0.3 | 0.5 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
| 0.3 | 0.5 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 0.3 | 0.3 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
| 0.3 | 1.4 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 0.3 | 1.1 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.3 | 0.8 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.3 | 0.3 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
| 0.3 | 1.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.3 | 1.9 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
| 0.3 | 1.3 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
| 0.3 | 4.6 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.3 | 1.1 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.3 | 0.8 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.3 | 0.3 | GO:0071220 | response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) |
| 0.3 | 0.5 | GO:2000705 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.3 | 2.4 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.3 | 0.8 | GO:0045110 | neurofilament bundle assembly(GO:0033693) intermediate filament bundle assembly(GO:0045110) |
| 0.3 | 11.1 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
| 0.3 | 0.5 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
| 0.3 | 2.1 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
| 0.3 | 0.8 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
| 0.3 | 5.7 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.3 | 6.8 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
| 0.3 | 2.9 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.3 | 1.6 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.3 | 0.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.3 | 2.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.3 | 2.6 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
| 0.3 | 1.6 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.3 | 0.5 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.3 | 0.3 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
| 0.3 | 1.3 | GO:1900118 | suppression by virus of host apoptotic process(GO:0019050) negative regulation by symbiont of host apoptotic process(GO:0033668) modulation by virus of host apoptotic process(GO:0039526) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) negative regulation of execution phase of apoptosis(GO:1900118) |
| 0.3 | 0.5 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.3 | 0.8 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.3 | 0.3 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.3 | 0.5 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.3 | 1.8 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.3 | 0.5 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.3 | 1.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
| 0.3 | 0.8 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.3 | 0.3 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.3 | 0.3 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.3 | 4.8 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
| 0.3 | 7.1 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.3 | 0.8 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
| 0.3 | 2.0 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.3 | 2.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
| 0.3 | 0.8 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.3 | 0.3 | GO:0099612 | protein localization to axon(GO:0099612) |
| 0.3 | 5.6 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.3 | 0.5 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) |
| 0.3 | 5.6 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.3 | 1.0 | GO:0006569 | tryptophan catabolic process(GO:0006569) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
| 0.3 | 4.0 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
| 0.3 | 0.8 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.3 | 0.5 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.3 | 2.0 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
| 0.3 | 1.0 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.3 | 5.8 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.3 | 5.8 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.2 | 0.2 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.2 | 5.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.2 | 1.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.2 | 0.7 | GO:0048318 | axial mesoderm development(GO:0048318) |
| 0.2 | 2.5 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.2 | 0.2 | GO:2000848 | positive regulation of corticosteroid hormone secretion(GO:2000848) |
| 0.2 | 2.7 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.2 | 3.0 | GO:0032196 | transposition(GO:0032196) |
| 0.2 | 0.7 | GO:0008358 | oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
| 0.2 | 1.7 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.2 | 0.5 | GO:1904729 | regulation of intestinal cholesterol absorption(GO:0030300) negative regulation of intestinal absorption(GO:1904479) regulation of intestinal lipid absorption(GO:1904729) |
| 0.2 | 0.2 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
| 0.2 | 1.0 | GO:0036102 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.2 | 0.5 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
| 0.2 | 2.4 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.2 | 0.5 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
| 0.2 | 1.0 | GO:0048749 | compound eye development(GO:0048749) |
| 0.2 | 0.5 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
| 0.2 | 1.0 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
| 0.2 | 2.6 | GO:0050432 | catecholamine secretion(GO:0050432) |
| 0.2 | 0.5 | GO:0002118 | aggressive behavior(GO:0002118) |
| 0.2 | 1.2 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
| 0.2 | 6.9 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
| 0.2 | 0.2 | GO:0050955 | thermoception(GO:0050955) |
| 0.2 | 1.7 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.2 | 0.9 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
| 0.2 | 3.6 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.2 | 0.7 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.2 | 1.2 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.2 | 2.6 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.2 | 3.8 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
| 0.2 | 1.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.2 | 1.4 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 0.2 | 2.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.2 | 2.3 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.2 | 1.6 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.2 | 1.2 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.2 | 3.0 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.2 | 0.7 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.2 | 2.5 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.2 | 1.2 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 0.2 | 0.5 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.2 | 0.2 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.2 | 1.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.2 | 11.7 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.2 | 1.1 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.2 | 1.4 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.2 | 0.5 | GO:0051659 | maintenance of mitochondrion location(GO:0051659) |
| 0.2 | 0.9 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.2 | 0.5 | GO:0071873 | response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
| 0.2 | 0.7 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
| 0.2 | 2.0 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.2 | 2.0 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.2 | 0.7 | GO:0048560 | establishment of anatomical structure orientation(GO:0048560) |
| 0.2 | 1.1 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.2 | 1.6 | GO:0019695 | choline metabolic process(GO:0019695) |
| 0.2 | 0.9 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.2 | 0.7 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.2 | 0.2 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
| 0.2 | 1.1 | GO:0042268 | regulation of cytolysis(GO:0042268) |
| 0.2 | 1.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.2 | 1.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.2 | 0.7 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.2 | 7.8 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.2 | 1.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.2 | 0.9 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 0.2 | 2.7 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
| 0.2 | 4.2 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.2 | 1.8 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.2 | 0.2 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
| 0.2 | 2.0 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.2 | 0.7 | GO:0072679 | thymocyte migration(GO:0072679) |
| 0.2 | 4.0 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.2 | 3.8 | GO:0048753 | pigment granule organization(GO:0048753) |
| 0.2 | 1.5 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.2 | 1.5 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.2 | 1.1 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.2 | 18.2 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
| 0.2 | 3.5 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
| 0.2 | 3.5 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.2 | 0.7 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.2 | 0.9 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.2 | 4.8 | GO:0034204 | lipid translocation(GO:0034204) |
| 0.2 | 2.2 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.2 | 5.2 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
| 0.2 | 1.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.2 | 1.3 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.2 | 1.5 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.2 | 4.5 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.2 | 1.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.2 | 5.0 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.2 | 0.2 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
| 0.2 | 0.2 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.2 | 0.4 | GO:0035937 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) positive regulation of estrogen secretion(GO:2000863) regulation of estradiol secretion(GO:2000864) positive regulation of estradiol secretion(GO:2000866) |
| 0.2 | 0.4 | GO:0019470 | glyoxylate catabolic process(GO:0009436) 4-hydroxyproline catabolic process(GO:0019470) |
| 0.2 | 0.2 | GO:0051409 | response to nitrosative stress(GO:0051409) |
| 0.2 | 1.9 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.2 | 3.6 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.2 | 4.9 | GO:0014850 | response to muscle activity(GO:0014850) |
| 0.2 | 0.6 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.2 | 0.8 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
| 0.2 | 0.2 | GO:0051541 | elastin metabolic process(GO:0051541) elastin catabolic process(GO:0060309) |
| 0.2 | 0.6 | GO:1903259 | exon-exon junction complex disassembly(GO:1903259) |
| 0.2 | 0.4 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.2 | 1.5 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.2 | 10.7 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
| 0.2 | 0.8 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.2 | 0.6 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.2 | 0.2 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.2 | 1.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.2 | 2.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.2 | 1.0 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.2 | 2.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) negative regulation of biomineral tissue development(GO:0070168) |
| 0.2 | 0.8 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
| 0.2 | 0.8 | GO:0097205 | renal filtration(GO:0097205) |
| 0.2 | 0.2 | GO:0051532 | regulation of NFAT protein import into nucleus(GO:0051532) |
| 0.2 | 1.4 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.2 | 0.8 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.2 | 0.6 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.2 | 2.2 | GO:0060026 | convergent extension(GO:0060026) |
| 0.2 | 0.8 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.2 | 0.8 | GO:0035803 | egg coat formation(GO:0035803) |
| 0.2 | 30.1 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.2 | 0.6 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 0.2 | 5.4 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.2 | 0.2 | GO:0002664 | regulation of T cell tolerance induction(GO:0002664) |
| 0.2 | 1.2 | GO:0001825 | blastocyst formation(GO:0001825) |
| 0.2 | 11.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.2 | 0.6 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
| 0.2 | 1.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 0.2 | 0.6 | GO:0072114 | regulation of pronephros size(GO:0035565) pronephros morphogenesis(GO:0072114) |
| 0.2 | 1.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.2 | 0.4 | GO:0097106 | postsynaptic density organization(GO:0097106) |
| 0.2 | 1.8 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
| 0.2 | 0.4 | GO:0009631 | cold acclimation(GO:0009631) |
| 0.2 | 0.8 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.2 | 0.8 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.2 | 0.2 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.2 | 0.6 | GO:1901656 | glucoside transport(GO:0042946) glycoside transport(GO:1901656) |
| 0.2 | 0.6 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
| 0.2 | 1.2 | GO:1902074 | response to salt(GO:1902074) |
| 0.2 | 8.8 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.2 | 1.4 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 0.2 | 1.2 | GO:0019474 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 0.2 | 1.4 | GO:0009176 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
| 0.2 | 1.2 | GO:0046697 | decidualization(GO:0046697) |
| 0.2 | 13.1 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
| 0.2 | 0.8 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.2 | 2.3 | GO:0030091 | protein repair(GO:0030091) |
| 0.2 | 4.4 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
| 0.2 | 1.0 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.2 | 0.4 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
| 0.2 | 0.8 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
| 0.2 | 1.1 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
| 0.2 | 1.0 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.2 | 3.0 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.2 | 1.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
| 0.2 | 4.4 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.2 | 1.7 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
| 0.2 | 0.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.2 | 0.2 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
| 0.2 | 1.7 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.2 | 0.2 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.2 | 0.2 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.2 | 7.7 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
| 0.2 | 1.3 | GO:0002254 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
| 0.2 | 14.1 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.2 | 0.4 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
| 0.2 | 1.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.2 | 0.2 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
| 0.2 | 2.4 | GO:0033198 | response to ATP(GO:0033198) |
| 0.2 | 3.2 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.2 | 1.1 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.2 | 0.6 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.2 | 3.1 | GO:0051602 | response to electrical stimulus(GO:0051602) |
| 0.2 | 0.7 | GO:0051597 | response to methylmercury(GO:0051597) |
| 0.2 | 6.3 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.2 | 0.5 | GO:0002818 | intracellular defense response(GO:0002818) |
| 0.2 | 1.1 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.2 | 0.5 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.2 | 3.6 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
| 0.2 | 0.7 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.2 | 10.3 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
| 0.2 | 2.9 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.2 | 0.7 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.2 | 1.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.2 | 2.7 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.2 | 11.8 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.2 | 0.4 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
| 0.2 | 8.9 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.2 | 0.4 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 0.2 | 0.4 | GO:0032571 | response to vitamin K(GO:0032571) |
| 0.2 | 0.2 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.2 | 0.2 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
| 0.2 | 0.5 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.2 | 0.5 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.2 | 0.3 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
| 0.2 | 0.7 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.2 | 0.7 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.2 | 0.9 | GO:0007619 | courtship behavior(GO:0007619) |
| 0.2 | 0.5 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.2 | 0.3 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) |
| 0.2 | 0.9 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.2 | 0.3 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.2 | 1.0 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.2 | 0.7 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.2 | 0.5 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.2 | 0.7 | GO:1900247 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.2 | 0.5 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 0.2 | 0.5 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 0.2 | 0.5 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
| 0.2 | 1.0 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.2 | 0.3 | GO:0044062 | regulation of excretion(GO:0044062) |
| 0.2 | 0.2 | GO:0002339 | B cell selection(GO:0002339) |
| 0.2 | 0.3 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.2 | 0.2 | GO:0051917 | regulation of fibrinolysis(GO:0051917) |
| 0.2 | 0.5 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.2 | 1.6 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.2 | 2.9 | GO:0043029 | T cell homeostasis(GO:0043029) |
| 0.2 | 0.6 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.2 | 1.1 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.2 | 0.5 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
| 0.2 | 0.3 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.2 | 2.5 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.2 | 0.8 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.2 | 0.6 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.2 | 0.5 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.2 | 4.2 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.2 | 0.8 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.2 | 0.5 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.2 | 1.7 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.2 | 0.5 | GO:0005984 | maltose metabolic process(GO:0000023) disaccharide metabolic process(GO:0005984) |
| 0.2 | 0.5 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.2 | 0.6 | GO:0030472 | mitotic spindle organization in nucleus(GO:0030472) |
| 0.2 | 0.5 | GO:0035048 | splicing factor protein import into nucleus(GO:0035048) |
| 0.2 | 2.5 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.2 | 0.9 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.2 | 0.3 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
| 0.2 | 2.7 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
| 0.2 | 0.2 | GO:0036245 | cellular response to menadione(GO:0036245) |
| 0.2 | 0.5 | GO:2000109 | regulation of macrophage apoptotic process(GO:2000109) |
| 0.2 | 0.9 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.2 | 1.5 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.2 | 0.3 | GO:0042745 | circadian sleep/wake cycle process(GO:0022410) circadian sleep/wake cycle(GO:0042745) circadian sleep/wake cycle, sleep(GO:0050802) |
| 0.2 | 1.5 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
| 0.2 | 0.3 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.2 | 0.6 | GO:0060065 | uterus development(GO:0060065) |
| 0.2 | 2.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.2 | 4.5 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.1 | 0.1 | GO:0044209 | AMP salvage(GO:0044209) |
| 0.1 | 0.9 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
| 0.1 | 0.1 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
| 0.1 | 0.3 | GO:0010888 | negative regulation of lipid storage(GO:0010888) |
| 0.1 | 0.3 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
| 0.1 | 0.6 | GO:0010585 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.1 | 0.3 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 0.1 | 0.4 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
| 0.1 | 2.6 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.1 | 2.8 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 | 0.4 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
| 0.1 | 2.0 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.1 | 0.6 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.1 | 0.6 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.1 | 0.3 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
| 0.1 | 1.3 | GO:0050872 | white fat cell differentiation(GO:0050872) |
| 0.1 | 0.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.1 | 1.1 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.1 | 6.7 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.1 | 0.3 | GO:1903412 | response to bile acid(GO:1903412) |
| 0.1 | 7.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 | 1.8 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.1 | 0.8 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.1 | 0.7 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.1 | 0.6 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.1 | 0.8 | GO:0035588 | G-protein coupled purinergic receptor signaling pathway(GO:0035588) |
| 0.1 | 0.4 | GO:0015847 | putrescine transport(GO:0015847) |
| 0.1 | 0.1 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.1 | 1.4 | GO:0008088 | axo-dendritic transport(GO:0008088) |
| 0.1 | 0.8 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.1 | 2.5 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 | 0.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.1 | 3.8 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.1 | 1.1 | GO:0051969 | regulation of transmission of nerve impulse(GO:0051969) |
| 0.1 | 0.4 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.1 | 0.1 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
| 0.1 | 0.7 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
| 0.1 | 1.1 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
| 0.1 | 2.7 | GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
| 0.1 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
| 0.1 | 0.5 | GO:0007512 | adult heart development(GO:0007512) |
| 0.1 | 2.2 | GO:0009303 | rRNA transcription(GO:0009303) |
| 0.1 | 0.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.1 | 0.4 | GO:0003360 | brainstem development(GO:0003360) |
| 0.1 | 0.7 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 0.1 | 0.5 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.1 | 0.1 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
| 0.1 | 3.0 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
| 0.1 | 0.3 | GO:0048867 | stem cell fate determination(GO:0048867) |
| 0.1 | 0.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.1 | 0.5 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 | 0.5 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.1 | 2.0 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.1 | 2.5 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
| 0.1 | 0.7 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.1 | 1.3 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
| 0.1 | 4.0 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.1 | 0.3 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
| 0.1 | 0.8 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.1 | 1.2 | GO:1902745 | positive regulation of lamellipodium organization(GO:1902745) |
| 0.1 | 9.4 | GO:0050770 | regulation of axonogenesis(GO:0050770) |
| 0.1 | 0.4 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.1 | 1.7 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.1 | 3.5 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.1 | 3.5 | GO:0097553 | calcium ion transmembrane import into cytosol(GO:0097553) calcium ion import into cytosol(GO:1902656) |
| 0.1 | 2.5 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.1 | 3.4 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.1 | 0.4 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.1 | 0.8 | GO:0072319 | vesicle uncoating(GO:0072319) |
| 0.1 | 0.3 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.1 | 0.3 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
| 0.1 | 2.1 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
| 0.1 | 1.0 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.1 | 0.8 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
| 0.1 | 0.5 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.1 | 0.1 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
| 0.1 | 4.3 | GO:0043266 | regulation of potassium ion transport(GO:0043266) |
| 0.1 | 0.1 | GO:0090427 | activation of meiosis(GO:0090427) |
| 0.1 | 1.2 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
| 0.1 | 1.0 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.1 | 0.6 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.1 | 0.4 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.1 | 0.7 | GO:0035878 | nail development(GO:0035878) |
| 0.1 | 0.9 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.1 | 0.5 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 0.1 | 1.8 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 | 1.1 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
| 0.1 | 0.5 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.1 | 0.2 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.1 | 0.2 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 0.1 | 0.5 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.1 | 0.2 | GO:0019046 | release from viral latency(GO:0019046) |
| 0.1 | 1.2 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.1 | 0.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.1 | 1.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.1 | 0.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 0.1 | 0.8 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 | 5.0 | GO:0044364 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.1 | 0.1 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 | 0.4 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.1 | 8.1 | GO:0007030 | Golgi organization(GO:0007030) |
| 0.1 | 4.1 | GO:0031577 | spindle checkpoint(GO:0031577) |
| 0.1 | 0.3 | GO:0051645 | Golgi localization(GO:0051645) |
| 0.1 | 0.9 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.1 | 1.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 | 0.1 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.1 | 7.9 | GO:0051592 | response to calcium ion(GO:0051592) |
| 0.1 | 0.2 | GO:0007135 | meiosis II(GO:0007135) |
| 0.1 | 0.3 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
| 0.1 | 2.3 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 0.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.1 | 0.6 | GO:0015886 | heme transport(GO:0015886) |
| 0.1 | 0.9 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
| 0.1 | 0.8 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.1 | 0.2 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
| 0.1 | 0.6 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.1 | 0.2 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 | 1.7 | GO:0008089 | anterograde axonal transport(GO:0008089) |
| 0.1 | 0.6 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.1 | 0.9 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 | 2.1 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.1 | 1.3 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.1 | 0.3 | GO:0042819 | pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 biosynthetic process(GO:0042819) |
| 0.1 | 1.1 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
| 0.1 | 0.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.1 | 0.7 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
| 0.1 | 0.2 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) |
| 0.1 | 0.1 | GO:0010288 | response to lead ion(GO:0010288) |
| 0.1 | 4.6 | GO:0006939 | smooth muscle contraction(GO:0006939) |
| 0.1 | 0.2 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.1 | 0.4 | GO:0072092 | ureteric bud invasion(GO:0072092) |
| 0.1 | 0.2 | GO:0060022 | hard palate development(GO:0060022) |
| 0.1 | 0.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.1 | 0.4 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.1 | 0.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.1 | 0.2 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.1 | 1.0 | GO:0030220 | platelet formation(GO:0030220) |
| 0.1 | 0.7 | GO:0098743 | cell aggregation(GO:0098743) |
| 0.1 | 0.6 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
| 0.1 | 0.3 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 0.1 | 0.8 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 0.1 | 5.6 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
| 0.1 | 0.5 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.1 | 0.4 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
| 0.1 | 1.6 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
| 0.1 | 1.7 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.1 | 1.3 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
| 0.1 | 1.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
| 0.1 | 1.1 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.1 | 0.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 | 2.5 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.1 | 0.5 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.1 | 0.7 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
| 0.1 | 0.7 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.1 | 0.7 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
| 0.1 | 0.9 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
| 0.1 | 0.2 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
| 0.1 | 3.4 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 0.1 | 0.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 | 0.3 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
| 0.1 | 0.5 | GO:0015864 | uridine transport(GO:0015862) pyrimidine nucleoside transport(GO:0015864) |
| 0.1 | 0.8 | GO:0048311 | mitochondrion distribution(GO:0048311) |
| 0.1 | 10.1 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.1 | 0.6 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
| 0.1 | 0.3 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.1 | 0.3 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
| 0.1 | 0.7 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.1 | 0.3 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
| 0.1 | 0.8 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
| 0.1 | 1.9 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.1 | 1.5 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
| 0.1 | 0.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.1 | 0.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.1 | 0.3 | GO:0071888 | macrophage apoptotic process(GO:0071888) |
| 0.1 | 0.5 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.1 | 0.6 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.1 | 0.1 | GO:0019086 | late viral transcription(GO:0019086) |
| 0.1 | 0.9 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.1 | 2.0 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 | 0.4 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 | 0.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 | 1.3 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.1 | 7.2 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
| 0.1 | 1.8 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.1 | 0.1 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) regulation of serine-type peptidase activity(GO:1902571) |
| 0.1 | 6.5 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.1 | 0.5 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.1 | 0.2 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.1 | 0.2 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
| 0.1 | 0.3 | GO:0030238 | male sex determination(GO:0030238) |
| 0.1 | 0.2 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.1 | 0.2 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.1 | 0.8 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.1 | 1.5 | GO:0006937 | regulation of muscle contraction(GO:0006937) |
| 0.1 | 0.3 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.1 | 1.0 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.1 | 0.2 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.1 | 0.5 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.1 | 0.2 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 0.1 | 0.2 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
| 0.1 | 0.3 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.1 | 0.2 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.1 | 0.6 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
| 0.1 | 0.1 | GO:0090505 | wound healing, spreading of cells(GO:0044319) epiboly involved in wound healing(GO:0090505) |
| 0.1 | 0.8 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 | 0.4 | GO:0030261 | chromosome condensation(GO:0030261) |
| 0.1 | 0.2 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
| 0.1 | 2.7 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
| 0.1 | 0.1 | GO:0046072 | dUDP biosynthetic process(GO:0006227) dTDP biosynthetic process(GO:0006233) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dTDP metabolic process(GO:0046072) dUDP metabolic process(GO:0046077) |
| 0.1 | 0.6 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 | 0.1 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
| 0.1 | 0.2 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
| 0.1 | 0.3 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 0.1 | 0.1 | GO:0009136 | ADP biosynthetic process(GO:0006172) nucleoside diphosphate biosynthetic process(GO:0009133) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 0.1 | 0.1 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.1 | 1.7 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.1 | 0.3 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
| 0.1 | 0.1 | GO:0060699 | regulation of endoribonuclease activity(GO:0060699) |
| 0.1 | 3.4 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 | 0.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.1 | 0.2 | GO:0031627 | telomeric loop formation(GO:0031627) |
| 0.1 | 11.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.1 | 0.1 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 0.1 | 0.1 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
| 0.1 | 0.5 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 0.1 | 0.5 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 | 1.1 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
| 0.1 | 0.4 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
| 0.1 | 0.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.1 | 0.9 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.1 | 0.6 | GO:0097035 | regulation of membrane lipid distribution(GO:0097035) |
| 0.1 | 0.2 | GO:0051758 | homologous chromosome movement towards spindle pole involved in homologous chromosome segregation(GO:0051758) |
| 0.1 | 0.1 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
| 0.1 | 0.1 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
| 0.1 | 0.2 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
| 0.1 | 0.3 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 0.1 | 0.1 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.1 | 0.4 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
| 0.1 | 0.1 | GO:0048799 | organ maturation(GO:0048799) |
| 0.1 | 0.2 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.1 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 0.1 | 0.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.1 | 0.6 | GO:0070266 | necroptotic process(GO:0070266) |
| 0.1 | 2.0 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.1 | 0.2 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) positive regulation of ERK5 cascade(GO:0070378) |
| 0.1 | 1.4 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 | 0.6 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 | 1.9 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
| 0.1 | 0.2 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
| 0.1 | 0.1 | GO:1904616 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.1 | 0.5 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.1 | 0.4 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.1 | 0.2 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.1 | 0.2 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
| 0.1 | 0.7 | GO:1900115 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.1 | 0.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 | 0.6 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
| 0.1 | 0.3 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
| 0.1 | 0.1 | GO:1901970 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.1 | 0.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.1 | 0.7 | GO:0033574 | response to testosterone(GO:0033574) |
| 0.1 | 0.1 | GO:1903217 | regulation of protein processing involved in protein targeting to mitochondrion(GO:1903216) negative regulation of protein processing involved in protein targeting to mitochondrion(GO:1903217) |
| 0.1 | 0.2 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
| 0.1 | 0.2 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 0.1 | 0.9 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.1 | 0.2 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
| 0.0 | 0.1 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.0 | 0.3 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
| 0.0 | 0.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.0 | 0.9 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
| 0.0 | 0.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.0 | 0.3 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.0 | 0.0 | GO:0007028 | cytoplasm organization(GO:0007028) |
| 0.0 | 0.1 | GO:0006829 | zinc II ion transport(GO:0006829) |
| 0.0 | 0.1 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.0 | 0.5 | GO:0019068 | virion assembly(GO:0019068) |
| 0.0 | 1.5 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.0 | 0.4 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.0 | 1.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 0.0 | 0.5 | GO:0060048 | cardiac muscle contraction(GO:0060048) |
| 0.0 | 0.1 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.0 | 0.1 | GO:0042040 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.0 | 0.1 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
| 0.0 | 0.2 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.0 | 0.5 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 | 0.2 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
| 0.0 | 0.6 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
| 0.0 | 0.1 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
| 0.0 | 0.2 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.0 | 0.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.0 | 0.5 | GO:0008361 | regulation of cell size(GO:0008361) |
| 0.0 | 0.0 | GO:0014741 | negative regulation of muscle hypertrophy(GO:0014741) |
| 0.0 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.0 | 0.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 | 0.3 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.0 | 0.1 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
| 0.0 | 0.2 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) |
| 0.0 | 0.4 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.0 | 1.1 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.0 | 0.4 | GO:0006734 | NADH metabolic process(GO:0006734) |
| 0.0 | 0.1 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
| 0.0 | 0.7 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
| 0.0 | 0.2 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.0 | 0.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.0 | 0.0 | GO:1903337 | positive regulation of vacuolar transport(GO:1903337) |
| 0.0 | 0.3 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.0 | 0.1 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.0 | 0.1 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.0 | 1.5 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 | 0.7 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
| 0.0 | 0.1 | GO:0090024 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 0.0 | 0.2 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.0 | 0.1 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.0 | 0.2 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.0 | 0.2 | GO:0030638 | polyketide metabolic process(GO:0030638) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.0 | 0.2 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.0 | 0.0 | GO:0021539 | subthalamus development(GO:0021539) |
| 0.0 | 0.1 | GO:0030431 | sleep(GO:0030431) |
| 0.0 | 0.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.0 | 0.3 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) |
| 0.0 | 0.8 | GO:0030183 | B cell differentiation(GO:0030183) |
| 0.0 | 0.1 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
| 0.0 | 0.1 | GO:0002349 | histamine secretion(GO:0001821) histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) histamine transport(GO:0051608) |
| 0.0 | 0.1 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.0 | 0.6 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
| 0.0 | 0.2 | GO:1903011 | negative regulation of bone development(GO:1903011) negative regulation of osteoclast development(GO:2001205) |
| 0.0 | 0.1 | GO:0031296 | B cell costimulation(GO:0031296) |
| 0.0 | 0.1 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.0 | 0.0 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) |
| 0.0 | 0.3 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
| 0.0 | 0.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.0 | 0.1 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
| 0.0 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
| 0.0 | 0.6 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.0 | 0.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.0 | 0.2 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
| 0.0 | 0.0 | GO:0072366 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.0 | 0.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
| 0.0 | 0.9 | GO:0043486 | histone exchange(GO:0043486) |
| 0.0 | 0.1 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.0 | 0.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.0 | 0.3 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
| 0.0 | 0.4 | GO:0035036 | sperm-egg recognition(GO:0035036) |
| 0.0 | 0.1 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
| 0.0 | 0.1 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.0 | 0.1 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
| 0.0 | 0.0 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
| 0.0 | 0.1 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
| 0.0 | 0.0 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.0 | 0.1 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
| 0.0 | 0.0 | GO:0044546 | NLRP3 inflammasome complex assembly(GO:0044546) |
| 0.0 | 0.1 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
| 0.0 | 0.0 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 8.7 | 61.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 3.5 | 14.1 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 3.3 | 10.0 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 2.6 | 15.8 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 2.5 | 7.5 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 2.4 | 14.7 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 2.4 | 11.9 | GO:0031528 | microvillus membrane(GO:0031528) |
| 2.4 | 7.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 2.2 | 11.1 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 2.1 | 10.6 | GO:0031523 | Myb complex(GO:0031523) |
| 2.1 | 6.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 2.0 | 6.0 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 2.0 | 17.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 1.9 | 9.6 | GO:0045160 | myosin I complex(GO:0045160) |
| 1.8 | 10.7 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 1.7 | 6.9 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 1.7 | 6.6 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 1.6 | 8.2 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 1.6 | 4.8 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 1.6 | 25.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 1.6 | 38.2 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 1.6 | 6.3 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 1.4 | 21.0 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 1.4 | 4.1 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 1.4 | 5.4 | GO:0005595 | collagen type XII trimer(GO:0005595) |
| 1.3 | 10.4 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 1.2 | 12.3 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
| 1.2 | 12.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 1.2 | 13.0 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 1.2 | 1.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 1.1 | 19.5 | GO:0005861 | troponin complex(GO:0005861) |
| 1.1 | 5.7 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 1.1 | 4.4 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
| 1.1 | 10.9 | GO:0097443 | sorting endosome(GO:0097443) |
| 1.1 | 4.3 | GO:0039713 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
| 1.1 | 6.4 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 1.0 | 4.1 | GO:1990032 | parallel fiber(GO:1990032) |
| 1.0 | 1.0 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
| 1.0 | 1.0 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
| 1.0 | 4.0 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
| 1.0 | 17.9 | GO:0008091 | spectrin(GO:0008091) |
| 1.0 | 5.0 | GO:0032449 | CBM complex(GO:0032449) |
| 1.0 | 2.9 | GO:0055087 | Ski complex(GO:0055087) |
| 0.9 | 3.8 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 0.9 | 0.9 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 0.9 | 5.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.9 | 3.6 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.9 | 23.0 | GO:0005922 | connexon complex(GO:0005922) |
| 0.9 | 10.6 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.9 | 1.8 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.9 | 4.3 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.9 | 3.5 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.8 | 1.7 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 0.8 | 8.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.8 | 4.2 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.8 | 10.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.8 | 0.8 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 0.8 | 0.8 | GO:0044393 | microspike(GO:0044393) |
| 0.8 | 3.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.8 | 2.5 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 0.8 | 14.8 | GO:0045180 | basal cortex(GO:0045180) |
| 0.8 | 47.7 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.8 | 2.5 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
| 0.8 | 8.4 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.8 | 17.5 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.8 | 2.3 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.8 | 0.8 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
| 0.8 | 1.5 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.8 | 7.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.7 | 3.0 | GO:0033643 | host cell part(GO:0033643) |
| 0.7 | 2.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.7 | 7.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.7 | 4.3 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.7 | 37.4 | GO:0030673 | axolemma(GO:0030673) |
| 0.7 | 3.5 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.7 | 14.7 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.7 | 2.1 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 0.7 | 8.2 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.7 | 2.6 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 0.6 | 9.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.6 | 1.9 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
| 0.6 | 10.7 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 0.6 | 0.6 | GO:0097386 | glial cell projection(GO:0097386) |
| 0.6 | 1.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.6 | 3.0 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
| 0.6 | 1.8 | GO:0033593 | BRCA2-MAGE-D1 complex(GO:0033593) |
| 0.6 | 7.8 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.6 | 1.2 | GO:0015934 | large ribosomal subunit(GO:0015934) |
| 0.6 | 1.8 | GO:0055028 | cortical microtubule(GO:0055028) |
| 0.6 | 3.5 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 0.6 | 2.3 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.6 | 2.3 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.6 | 11.0 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.6 | 16.2 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.6 | 23.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.6 | 1.7 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
| 0.6 | 19.5 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.6 | 1.7 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 0.6 | 5.0 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.6 | 2.8 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.6 | 7.7 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.5 | 3.3 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.5 | 8.0 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.5 | 5.3 | GO:0071437 | invadopodium(GO:0071437) |
| 0.5 | 3.7 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
| 0.5 | 1.6 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 0.5 | 17.2 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.5 | 1.6 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.5 | 49.4 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.5 | 5.7 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.5 | 1.0 | GO:1990357 | terminal web(GO:1990357) |
| 0.5 | 4.1 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.5 | 5.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.5 | 10.1 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
| 0.5 | 7.0 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.5 | 1.5 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 0.5 | 2.0 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.5 | 2.0 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.5 | 1.0 | GO:0045179 | apical cortex(GO:0045179) |
| 0.5 | 2.0 | GO:0097229 | sperm end piece(GO:0097229) |
| 0.5 | 9.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.5 | 5.4 | GO:0032059 | bleb(GO:0032059) |
| 0.5 | 1.5 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 0.5 | 1.9 | GO:0033011 | perinuclear theca(GO:0033011) |
| 0.5 | 2.4 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
| 0.5 | 10.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.5 | 7.1 | GO:0030478 | actin cap(GO:0030478) |
| 0.5 | 4.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.5 | 2.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.5 | 5.1 | GO:0005638 | lamin filament(GO:0005638) |
| 0.5 | 2.3 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.5 | 7.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.5 | 3.6 | GO:0000796 | condensin complex(GO:0000796) |
| 0.5 | 8.1 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.5 | 0.5 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.4 | 7.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.4 | 1.8 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.4 | 3.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.4 | 43.2 | GO:0005604 | basement membrane(GO:0005604) |
| 0.4 | 0.4 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
| 0.4 | 0.9 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
| 0.4 | 3.0 | GO:0033503 | HULC complex(GO:0033503) |
| 0.4 | 0.4 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 0.4 | 19.7 | GO:0002102 | podosome(GO:0002102) |
| 0.4 | 1.7 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.4 | 4.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.4 | 1.3 | GO:0071756 | IgM immunoglobulin complex(GO:0071753) IgM immunoglobulin complex, circulating(GO:0071754) pentameric IgM immunoglobulin complex(GO:0071756) |
| 0.4 | 7.9 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.4 | 2.9 | GO:0032021 | NELF complex(GO:0032021) |
| 0.4 | 1.2 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
| 0.4 | 4.5 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.4 | 3.3 | GO:0071546 | pi-body(GO:0071546) |
| 0.4 | 2.4 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.4 | 33.7 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.4 | 4.5 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
| 0.4 | 1.6 | GO:1990393 | 3M complex(GO:1990393) |
| 0.4 | 1.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.4 | 2.0 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.4 | 3.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.4 | 7.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.4 | 9.1 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.4 | 11.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.4 | 0.4 | GO:0044301 | climbing fiber(GO:0044301) |
| 0.4 | 1.2 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.4 | 1.6 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
| 0.4 | 6.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.4 | 8.5 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.4 | 1.1 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.4 | 2.2 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.4 | 5.2 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.4 | 1.1 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 0.4 | 1.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
| 0.4 | 0.4 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 0.4 | 0.7 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.4 | 0.4 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
| 0.4 | 2.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.4 | 0.4 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.4 | 1.4 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.4 | 2.9 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.4 | 3.2 | GO:0098644 | complex of collagen trimers(GO:0098644) |
| 0.4 | 2.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.4 | 2.5 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.4 | 6.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.4 | 1.1 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.3 | 28.0 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.3 | 1.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.3 | 2.8 | GO:0031415 | NatA complex(GO:0031415) |
| 0.3 | 2.8 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.3 | 2.1 | GO:0051286 | cell tip(GO:0051286) |
| 0.3 | 2.7 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.3 | 5.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.3 | 0.3 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
| 0.3 | 1.0 | GO:0000805 | X chromosome(GO:0000805) |
| 0.3 | 2.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.3 | 2.3 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.3 | 6.9 | GO:0010369 | chromocenter(GO:0010369) |
| 0.3 | 3.3 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.3 | 3.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.3 | 0.7 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.3 | 1.9 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.3 | 6.1 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 0.3 | 3.8 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.3 | 41.4 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.3 | 2.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.3 | 0.6 | GO:0034515 | proteasome storage granule(GO:0034515) |
| 0.3 | 5.0 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.3 | 1.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.3 | 2.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.3 | 0.9 | GO:0043203 | axon hillock(GO:0043203) |
| 0.3 | 2.2 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.3 | 1.2 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
| 0.3 | 3.0 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.3 | 7.2 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.3 | 38.0 | GO:0005901 | caveola(GO:0005901) |
| 0.3 | 2.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 0.3 | 5.1 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.3 | 1.5 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
| 0.3 | 178.8 | GO:0030055 | cell-substrate junction(GO:0030055) |
| 0.3 | 3.3 | GO:0030057 | desmosome(GO:0030057) |
| 0.3 | 3.8 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.3 | 0.6 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.3 | 3.8 | GO:0031672 | A band(GO:0031672) |
| 0.3 | 0.3 | GO:0043159 | acrosomal matrix(GO:0043159) |
| 0.3 | 3.7 | GO:0005921 | gap junction(GO:0005921) |
| 0.3 | 1.1 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
| 0.3 | 2.2 | GO:0090543 | Flemming body(GO:0090543) |
| 0.3 | 4.7 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.3 | 1.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.3 | 1.4 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.3 | 1.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 0.3 | 3.3 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
| 0.3 | 1.9 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.3 | 11.4 | GO:0005884 | actin filament(GO:0005884) |
| 0.3 | 0.8 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 0.3 | 1.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.3 | 0.8 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.3 | 1.3 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.3 | 0.8 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.3 | 23.7 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.3 | 1.6 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.3 | 0.3 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.3 | 7.6 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.3 | 0.3 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.3 | 0.5 | GO:0071745 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
| 0.3 | 3.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.3 | 2.1 | GO:0032982 | myosin filament(GO:0032982) |
| 0.3 | 3.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.3 | 6.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.3 | 1.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.3 | 1.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.3 | 2.8 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.2 | 1.5 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.2 | 1.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.2 | 21.6 | GO:0016528 | sarcoplasm(GO:0016528) |
| 0.2 | 2.2 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.2 | 1.0 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.2 | 28.1 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.2 | 4.9 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.2 | 1.4 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.2 | 0.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.2 | 2.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.2 | 0.5 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
| 0.2 | 1.0 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.2 | 1.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
| 0.2 | 3.8 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.2 | 0.7 | GO:0097444 | spine apparatus(GO:0097444) |
| 0.2 | 1.4 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.2 | 0.9 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
| 0.2 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.2 | 31.9 | GO:0031674 | I band(GO:0031674) |
| 0.2 | 0.9 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.2 | 1.6 | GO:0070938 | contractile ring(GO:0070938) |
| 0.2 | 0.7 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.2 | 3.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.2 | 1.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.2 | 0.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.2 | 9.8 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.2 | 25.2 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.2 | 2.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.2 | 30.4 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.2 | 0.4 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 0.2 | 1.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.2 | 6.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.2 | 0.6 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 0.2 | 1.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.2 | 0.9 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
| 0.2 | 1.5 | GO:0000243 | commitment complex(GO:0000243) |
| 0.2 | 1.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.2 | 1.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.2 | 1.7 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
| 0.2 | 1.7 | GO:0043196 | varicosity(GO:0043196) |
| 0.2 | 0.6 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.2 | 1.7 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.2 | 4.6 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.2 | 1.4 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
| 0.2 | 51.3 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
| 0.2 | 8.0 | GO:0030016 | myofibril(GO:0030016) |
| 0.2 | 3.5 | GO:0032420 | stereocilium(GO:0032420) |
| 0.2 | 35.4 | GO:0001726 | ruffle(GO:0001726) |
| 0.2 | 0.6 | GO:0060342 | photoreceptor inner segment membrane(GO:0060342) |
| 0.2 | 24.3 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.2 | 0.6 | GO:0042599 | lamellar body(GO:0042599) |
| 0.2 | 1.4 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
| 0.2 | 1.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.2 | 8.2 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.2 | 0.6 | GO:0032419 | extrinsic component of lysosome membrane(GO:0032419) |
| 0.2 | 0.2 | GO:1990742 | microvesicle(GO:1990742) |
| 0.2 | 11.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.2 | 0.8 | GO:1990879 | CST complex(GO:1990879) |
| 0.2 | 0.8 | GO:0089701 | U2AF(GO:0089701) |
| 0.2 | 1.7 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.2 | 0.4 | GO:0043219 | lateral loop(GO:0043219) |
| 0.2 | 0.5 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 0.2 | 1.3 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.2 | 6.8 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.2 | 1.8 | GO:0032797 | SMN complex(GO:0032797) |
| 0.2 | 260.1 | GO:0005615 | extracellular space(GO:0005615) |
| 0.2 | 0.7 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.2 | 3.0 | GO:0046930 | pore complex(GO:0046930) |
| 0.2 | 3.5 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.2 | 0.3 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.2 | 2.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.2 | 1.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.2 | 1.8 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.2 | 1.3 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.2 | 4.3 | GO:0016235 | aggresome(GO:0016235) |
| 0.2 | 2.0 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.2 | 1.6 | GO:0044853 | plasma membrane raft(GO:0044853) |
| 0.2 | 2.5 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.2 | 0.8 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.2 | 5.8 | GO:0043197 | dendritic spine(GO:0043197) |
| 0.2 | 0.9 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.2 | 0.2 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
| 0.1 | 2.2 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.1 | 9.7 | GO:0042383 | sarcolemma(GO:0042383) |
| 0.1 | 3.1 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.1 | 0.3 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.1 | 0.6 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.1 | 2.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.1 | 0.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.1 | 1.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.1 | 13.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.1 | 0.9 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.1 | 2.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 0.3 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.1 | 0.8 | GO:0070449 | elongin complex(GO:0070449) |
| 0.1 | 2.0 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.1 | 0.9 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.1 | 0.1 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
| 0.1 | 2.5 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.1 | 0.8 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.1 | 3.4 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.1 | 0.6 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.1 | 4.2 | GO:0005902 | microvillus(GO:0005902) |
| 0.1 | 0.9 | GO:0097451 | glial limiting end-foot(GO:0097451) |
| 0.1 | 0.5 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.1 | 1.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.1 | 0.8 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.1 | 0.3 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 0.1 | 0.3 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
| 0.1 | 0.2 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.1 | 4.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 2.6 | GO:1990752 | microtubule end(GO:1990752) |
| 0.1 | 9.0 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.1 | 0.6 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.1 | 1.7 | GO:0042555 | MCM complex(GO:0042555) |
| 0.1 | 0.7 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.1 | 2.8 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.1 | 9.5 | GO:0070161 | anchoring junction(GO:0070161) |
| 0.1 | 0.5 | GO:0019814 | immunoglobulin complex(GO:0019814) |
| 0.1 | 0.3 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
| 0.1 | 0.4 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.1 | 8.1 | GO:0005776 | autophagosome(GO:0005776) |
| 0.1 | 0.5 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
| 0.1 | 0.4 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.1 | 6.2 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.1 | 0.6 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 1.6 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.1 | 0.6 | GO:0016589 | NURF complex(GO:0016589) |
| 0.1 | 3.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.1 | 0.4 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.1 | 1.5 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.1 | 3.0 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.1 | 0.3 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.1 | 0.9 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.1 | 0.8 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.1 | 3.3 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
| 0.1 | 0.2 | GO:0044308 | axonal spine(GO:0044308) |
| 0.1 | 10.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.1 | 0.1 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.1 | 0.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.1 | 0.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 0.1 | 5.1 | GO:0005811 | lipid particle(GO:0005811) |
| 0.1 | 0.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.1 | 12.1 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.1 | 0.3 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.1 | 12.4 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
| 0.1 | 0.3 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
| 0.1 | 1.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.1 | 0.9 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.1 | 0.2 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.1 | 0.3 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.1 | 5.4 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.1 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.1 | 7.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.1 | 0.2 | GO:0097409 | glial cytoplasmic inclusion(GO:0097409) classical Lewy body(GO:0097414) Lewy neurite(GO:0097462) Lewy body corona(GO:1990038) |
| 0.1 | 0.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.1 | 0.3 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.1 | 0.4 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 0.1 | 0.7 | GO:0008305 | integrin complex(GO:0008305) |
| 0.1 | 0.9 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.1 | 0.3 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.1 | 0.1 | GO:0034657 | GID complex(GO:0034657) |
| 0.0 | 0.6 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.0 | 0.0 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
| 0.0 | 0.1 | GO:0044609 | DBIRD complex(GO:0044609) |
| 0.0 | 12.2 | GO:0016324 | apical plasma membrane(GO:0016324) |
| 0.0 | 0.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.0 | 0.4 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.0 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.0 | 0.9 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.0 | 1.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.0 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.0 | 1.2 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.0 | 0.8 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.0 | 0.5 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.0 | 0.2 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.0 | 0.8 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.0 | 1.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.0 | 0.0 | GO:0045120 | pronucleus(GO:0045120) |
| 0.0 | 0.2 | GO:0042825 | TAP complex(GO:0042825) |
| 0.0 | 0.3 | GO:0001673 | male germ cell nucleus(GO:0001673) germ cell nucleus(GO:0043073) |
| 0.0 | 0.1 | GO:0061702 | inflammasome complex(GO:0061702) |
| 0.0 | 16.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.0 | 0.1 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.0 | 3.1 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.0 | 4.0 | GO:0015629 | actin cytoskeleton(GO:0015629) |
| 0.0 | 0.6 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
| 0.0 | 0.1 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
| 0.0 | 0.4 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
| 0.0 | 0.0 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.0 | 0.2 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
| 0.0 | 0.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.0 | 1.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.0 | 0.0 | GO:0000811 | GINS complex(GO:0000811) |
| 0.0 | 0.8 | GO:0005840 | ribosome(GO:0005840) |
| 0.0 | 2.3 | GO:0005769 | early endosome(GO:0005769) |
| 0.0 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
| 0.0 | 0.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.0 | 0.5 | GO:0034774 | secretory granule lumen(GO:0034774) |
| 0.0 | 15.8 | GO:0005730 | nucleolus(GO:0005730) |
| 0.0 | 1.5 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.0 | 0.1 | GO:0000938 | GARP complex(GO:0000938) |
| 0.0 | 0.1 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.0 | 0.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.0 | 0.0 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
| 0.0 | 0.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.5 | 13.5 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 3.9 | 11.8 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 3.6 | 17.9 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 3.5 | 14.1 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 3.3 | 16.5 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 3.3 | 13.1 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
| 3.2 | 29.2 | GO:0043426 | MRF binding(GO:0043426) |
| 3.0 | 3.0 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 2.9 | 14.7 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 2.9 | 14.6 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 2.6 | 7.7 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
| 2.4 | 9.8 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
| 2.2 | 9.0 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 2.2 | 9.0 | GO:0035501 | MH1 domain binding(GO:0035501) |
| 2.2 | 6.7 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 2.2 | 8.8 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 2.1 | 12.5 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 2.0 | 6.1 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 2.0 | 13.7 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 1.9 | 5.6 | GO:0030305 | heparanase activity(GO:0030305) |
| 1.8 | 5.5 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
| 1.8 | 14.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 1.8 | 10.7 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 1.8 | 3.5 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 1.8 | 24.8 | GO:0031014 | troponin T binding(GO:0031014) |
| 1.8 | 10.5 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 1.7 | 8.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 1.7 | 7.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 1.7 | 10.4 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 1.7 | 8.5 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 1.7 | 11.8 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 1.7 | 8.4 | GO:0030395 | lactose binding(GO:0030395) |
| 1.7 | 5.0 | GO:0008431 | vitamin E binding(GO:0008431) |
| 1.6 | 6.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 1.6 | 6.3 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 1.6 | 1.6 | GO:0045550 | geranylgeranyl reductase activity(GO:0045550) |
| 1.6 | 4.7 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 1.6 | 9.4 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 1.6 | 7.8 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 1.5 | 7.7 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
| 1.5 | 4.6 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 1.5 | 4.6 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 1.5 | 4.4 | GO:0000248 | C-5 sterol desaturase activity(GO:0000248) sterol desaturase activity(GO:0070704) |
| 1.5 | 4.4 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 1.4 | 8.6 | GO:0070004 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
| 1.4 | 17.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 1.4 | 7.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 1.4 | 4.2 | GO:0055100 | adiponectin binding(GO:0055100) |
| 1.4 | 5.6 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 1.4 | 26.0 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 1.4 | 15.0 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 1.4 | 6.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 1.3 | 4.0 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 1.3 | 5.3 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 1.3 | 8.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
| 1.3 | 5.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 1.3 | 9.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 1.3 | 14.1 | GO:0042731 | PH domain binding(GO:0042731) |
| 1.3 | 12.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 1.3 | 3.8 | GO:0032428 | sphingolipid activator protein activity(GO:0030290) beta-N-acetylgalactosaminidase activity(GO:0032428) |
| 1.3 | 3.8 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
| 1.2 | 3.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 1.2 | 1.2 | GO:0070905 | serine binding(GO:0070905) |
| 1.2 | 3.7 | GO:0033842 | N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity(GO:0033842) |
| 1.2 | 3.6 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
| 1.2 | 4.8 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 1.2 | 3.6 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 1.2 | 3.5 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
| 1.2 | 3.5 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 1.2 | 6.9 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 1.1 | 11.4 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
| 1.1 | 3.4 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 1.1 | 4.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 1.1 | 7.9 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
| 1.1 | 4.5 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
| 1.1 | 7.8 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 1.1 | 3.3 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
| 1.1 | 13.2 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 1.1 | 24.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 1.1 | 4.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 1.1 | 2.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 1.1 | 9.8 | GO:0034711 | inhibin binding(GO:0034711) |
| 1.1 | 14.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 1.1 | 11.7 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 1.1 | 344.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 1.1 | 5.3 | GO:0050436 | microfibril binding(GO:0050436) |
| 1.1 | 6.3 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 1.0 | 5.2 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 1.0 | 6.2 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) |
| 1.0 | 4.2 | GO:0004001 | adenosine kinase activity(GO:0004001) |
| 1.0 | 32.1 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 1.0 | 4.1 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
| 1.0 | 8.2 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 1.0 | 15.3 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
| 1.0 | 4.1 | GO:0043273 | CTPase activity(GO:0043273) |
| 1.0 | 5.1 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 1.0 | 11.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 1.0 | 1.0 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
| 1.0 | 19.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 1.0 | 19.1 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 1.0 | 4.0 | GO:0045569 | TRAIL binding(GO:0045569) |
| 1.0 | 3.0 | GO:0002113 | interleukin-33 binding(GO:0002113) |
| 1.0 | 2.9 | GO:0004021 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
| 1.0 | 3.9 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 1.0 | 4.9 | GO:0032810 | sterol response element binding(GO:0032810) |
| 1.0 | 3.9 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 1.0 | 4.8 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 1.0 | 4.8 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.9 | 8.5 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.9 | 3.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.9 | 2.7 | GO:0004314 | [acyl-carrier-protein] S-malonyltransferase activity(GO:0004314) 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
| 0.9 | 4.6 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
| 0.9 | 4.5 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.9 | 1.8 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.9 | 2.7 | GO:0004638 | phosphoribosylaminoimidazole carboxylase activity(GO:0004638) phosphoribosylaminoimidazolesuccinocarboxamide synthase activity(GO:0004639) |
| 0.9 | 3.6 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.9 | 8.1 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.9 | 5.3 | GO:0042835 | BRE binding(GO:0042835) |
| 0.9 | 4.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.9 | 2.6 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.9 | 8.8 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.9 | 5.2 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
| 0.9 | 4.3 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.9 | 10.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.9 | 4.3 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.9 | 6.0 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 0.8 | 8.5 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.8 | 5.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
| 0.8 | 8.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.8 | 4.2 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 0.8 | 3.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 0.8 | 17.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.8 | 2.5 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.8 | 2.5 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.8 | 9.0 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.8 | 2.5 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 0.8 | 4.9 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 0.8 | 11.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 0.8 | 4.9 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
| 0.8 | 7.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.8 | 3.2 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.8 | 8.8 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.8 | 18.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.8 | 9.5 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 0.8 | 0.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.8 | 5.5 | GO:0031432 | titin binding(GO:0031432) |
| 0.8 | 11.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.8 | 3.1 | GO:0019798 | procollagen-proline dioxygenase activity(GO:0019798) |
| 0.8 | 3.9 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.8 | 6.9 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.8 | 3.8 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.8 | 2.3 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.8 | 1.5 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.8 | 6.0 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.7 | 3.7 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.7 | 2.2 | GO:0052858 | peptidyl-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0052858) |
| 0.7 | 2.2 | GO:0009032 | thymidine phosphorylase activity(GO:0009032) pyrimidine-nucleoside phosphorylase activity(GO:0016154) |
| 0.7 | 2.2 | GO:0004056 | argininosuccinate lyase activity(GO:0004056) |
| 0.7 | 14.6 | GO:0019841 | retinol binding(GO:0019841) |
| 0.7 | 1.5 | GO:0086059 | voltage-gated calcium channel activity involved SA node cell action potential(GO:0086059) |
| 0.7 | 2.9 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
| 0.7 | 27.8 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.7 | 0.7 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
| 0.7 | 9.2 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.7 | 4.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 0.7 | 2.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.7 | 12.6 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.7 | 7.0 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.7 | 13.2 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
| 0.7 | 1.4 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.7 | 2.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.7 | 2.7 | GO:0052595 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
| 0.7 | 4.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 0.7 | 8.8 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.7 | 4.1 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 0.7 | 3.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.7 | 18.9 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.7 | 0.7 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 0.7 | 4.0 | GO:0017161 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 0.7 | 3.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.7 | 6.6 | GO:0089720 | caspase binding(GO:0089720) |
| 0.7 | 2.0 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.7 | 4.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.7 | 7.8 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.7 | 2.0 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 0.6 | 1.9 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.6 | 7.7 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.6 | 2.6 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 0.6 | 10.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.6 | 26.6 | GO:0005504 | fatty acid binding(GO:0005504) |
| 0.6 | 5.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.6 | 5.0 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.6 | 6.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.6 | 8.7 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.6 | 9.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.6 | 8.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.6 | 1.8 | GO:0052856 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.6 | 1.8 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.6 | 4.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.6 | 15.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.6 | 2.4 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 0.6 | 1.8 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.6 | 4.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 0.6 | 1.8 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.6 | 2.4 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.6 | 2.4 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 0.6 | 4.1 | GO:0005497 | androgen binding(GO:0005497) |
| 0.6 | 1.8 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
| 0.6 | 9.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.6 | 7.0 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.6 | 2.9 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.6 | 2.9 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.6 | 1.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.6 | 1.1 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
| 0.6 | 4.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.6 | 6.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.6 | 2.9 | GO:0004802 | transketolase activity(GO:0004802) |
| 0.6 | 1.7 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.6 | 0.6 | GO:0000035 | acyl binding(GO:0000035) |
| 0.6 | 11.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.6 | 2.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
| 0.6 | 0.6 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.6 | 2.3 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.6 | 3.4 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.6 | 11.2 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.6 | 10.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.6 | 2.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
| 0.6 | 1.7 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
| 0.6 | 5.5 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.6 | 9.4 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.5 | 12.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.5 | 2.2 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.5 | 25.1 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.5 | 1.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 0.5 | 2.2 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.5 | 3.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.5 | 1.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.5 | 1.6 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.5 | 1.1 | GO:0016890 | site-specific endodeoxyribonuclease activity, specific for altered base(GO:0016890) |
| 0.5 | 11.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.5 | 2.1 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 0.5 | 5.7 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.5 | 4.7 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.5 | 1.6 | GO:0047012 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity(GO:0047012) |
| 0.5 | 2.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
| 0.5 | 3.1 | GO:0008732 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 0.5 | 1.5 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
| 0.5 | 4.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.5 | 2.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.5 | 12.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.5 | 1.5 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.5 | 3.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.5 | 7.4 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.5 | 4.0 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.5 | 4.0 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.5 | 7.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.5 | 1.5 | GO:0004750 | ribulose-phosphate 3-epimerase activity(GO:0004750) |
| 0.5 | 2.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.5 | 9.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.5 | 9.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.5 | 1.9 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.5 | 2.9 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
| 0.5 | 1.0 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.5 | 1.5 | GO:0016794 | guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity(GO:0008893) diphosphoric monoester hydrolase activity(GO:0016794) |
| 0.5 | 1.4 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.5 | 1.4 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 0.5 | 2.9 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 0.5 | 2.9 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 0.5 | 11.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.5 | 5.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.5 | 4.7 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.5 | 1.4 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
| 0.5 | 1.9 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.5 | 0.9 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
| 0.5 | 3.8 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
| 0.5 | 1.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.5 | 3.3 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 0.5 | 1.4 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 0.5 | 1.4 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 0.5 | 0.9 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.5 | 1.4 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) |
| 0.5 | 4.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
| 0.5 | 2.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.5 | 1.8 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 0.5 | 3.2 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
| 0.5 | 1.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.4 | 1.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 0.4 | 1.8 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.4 | 0.9 | GO:0030619 | U1 snRNA binding(GO:0030619) |
| 0.4 | 20.3 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.4 | 1.8 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.4 | 3.5 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.4 | 1.8 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
| 0.4 | 7.4 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.4 | 1.3 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 0.4 | 10.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.4 | 38.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.4 | 27.8 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.4 | 18.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.4 | 1.3 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 0.4 | 3.9 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.4 | 12.9 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.4 | 0.4 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 0.4 | 0.9 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.4 | 5.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.4 | 2.5 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
| 0.4 | 2.5 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
| 0.4 | 6.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.4 | 2.5 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.4 | 1.3 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.4 | 1.7 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
| 0.4 | 0.4 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
| 0.4 | 3.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.4 | 3.3 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
| 0.4 | 1.2 | GO:0033265 | choline binding(GO:0033265) |
| 0.4 | 0.8 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.4 | 3.7 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.4 | 1.2 | GO:0034584 | piRNA binding(GO:0034584) |
| 0.4 | 1.2 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
| 0.4 | 0.8 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
| 0.4 | 1.6 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.4 | 3.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.4 | 1.6 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
| 0.4 | 2.4 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.4 | 3.2 | GO:0070728 | leucine binding(GO:0070728) |
| 0.4 | 2.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
| 0.4 | 4.9 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
| 0.4 | 4.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.4 | 6.0 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.4 | 34.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.4 | 3.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.4 | 9.9 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.4 | 0.4 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.4 | 8.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.4 | 3.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.4 | 5.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.4 | 1.2 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 0.4 | 3.5 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.4 | 7.4 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.4 | 3.5 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.4 | 23.2 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.4 | 3.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
| 0.4 | 1.5 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.4 | 1.9 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.4 | 3.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.4 | 48.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.4 | 1.5 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.4 | 1.1 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.4 | 0.8 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.4 | 2.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.4 | 1.1 | GO:0036219 | GTP diphosphatase activity(GO:0036219) 2-hydroxy-adenosine triphosphate pyrophosphatase activity(GO:0044713) 2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity(GO:0044714) ATP diphosphatase activity(GO:0047693) |
| 0.4 | 2.6 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.4 | 1.5 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
| 0.4 | 15.5 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.4 | 1.5 | GO:0004360 | glutamine-fructose-6-phosphate transaminase (isomerizing) activity(GO:0004360) |
| 0.4 | 1.9 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.4 | 0.7 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.4 | 1.5 | GO:0002046 | opsin binding(GO:0002046) |
| 0.4 | 0.7 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 0.4 | 1.5 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.4 | 1.9 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.4 | 1.5 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
| 0.4 | 14.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.4 | 5.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.4 | 4.8 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.4 | 1.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
| 0.4 | 4.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.4 | 1.8 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
| 0.4 | 1.8 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.4 | 1.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.4 | 1.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.4 | 6.9 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.4 | 1.8 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
| 0.4 | 2.9 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.4 | 0.4 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.4 | 1.8 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.4 | 1.1 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.4 | 19.3 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.4 | 1.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.4 | 1.1 | GO:0052825 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
| 0.3 | 2.8 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.3 | 8.0 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.3 | 3.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.3 | 1.7 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.3 | 1.7 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.3 | 2.8 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.3 | 2.1 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.3 | 2.7 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.3 | 4.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.3 | 3.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.3 | 0.3 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.3 | 2.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.3 | 17.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.3 | 6.0 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.3 | 9.0 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.3 | 1.3 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.3 | 0.3 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 0.3 | 1.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.3 | 0.7 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.3 | 2.3 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.3 | 1.6 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.3 | 1.6 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.3 | 10.8 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.3 | 1.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.3 | 34.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.3 | 1.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.3 | 1.3 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.3 | 1.3 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.3 | 1.9 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 0.3 | 3.2 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.3 | 6.1 | GO:0005522 | profilin binding(GO:0005522) |
| 0.3 | 1.0 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.3 | 7.6 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.3 | 1.6 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.3 | 1.0 | GO:0034618 | arginine binding(GO:0034618) |
| 0.3 | 1.9 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.3 | 1.6 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.3 | 10.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.3 | 1.3 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.3 | 5.0 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.3 | 3.1 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.3 | 1.9 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.3 | 0.9 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.3 | 2.8 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 0.3 | 2.5 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 0.3 | 2.8 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.3 | 1.2 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
| 0.3 | 1.2 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.3 | 1.9 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.3 | 0.6 | GO:0008061 | chitin binding(GO:0008061) |
| 0.3 | 3.7 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.3 | 1.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.3 | 0.9 | GO:0031755 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
| 0.3 | 0.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.3 | 2.4 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.3 | 6.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.3 | 0.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.3 | 0.9 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
| 0.3 | 11.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.3 | 1.5 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.3 | 0.9 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.3 | 0.9 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 0.3 | 2.9 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.3 | 1.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.3 | 4.9 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
| 0.3 | 1.5 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.3 | 2.6 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.3 | 1.4 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 0.3 | 1.4 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.3 | 0.9 | GO:0035473 | lipase binding(GO:0035473) |
| 0.3 | 1.1 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
| 0.3 | 2.8 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.3 | 1.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.3 | 3.9 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.3 | 0.6 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
| 0.3 | 3.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.3 | 0.8 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.3 | 2.5 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.3 | 1.7 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.3 | 53.6 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.3 | 1.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.3 | 9.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.3 | 6.3 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.3 | 0.8 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.3 | 1.4 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.3 | 2.7 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.3 | 3.0 | GO:0030284 | estrogen receptor activity(GO:0030284) |
| 0.3 | 1.1 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.3 | 1.9 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
| 0.3 | 1.9 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.3 | 0.8 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.3 | 0.8 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
| 0.3 | 2.7 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.3 | 1.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.3 | 2.4 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.3 | 0.5 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.3 | 0.8 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.3 | 0.8 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.3 | 0.3 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
| 0.3 | 0.8 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.3 | 0.3 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
| 0.3 | 1.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.3 | 1.5 | GO:0005536 | glucose binding(GO:0005536) |
| 0.3 | 1.5 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.3 | 1.3 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
| 0.3 | 0.8 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
| 0.3 | 0.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.3 | 1.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.3 | 1.0 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.3 | 13.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.2 | 7.0 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.2 | 1.0 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.2 | 0.7 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.2 | 5.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.2 | 0.5 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
| 0.2 | 0.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.2 | 2.9 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.2 | 5.1 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.2 | 12.8 | GO:0061650 | ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 0.2 | 0.7 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
| 0.2 | 0.7 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
| 0.2 | 2.9 | GO:0046790 | virion binding(GO:0046790) |
| 0.2 | 5.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.2 | 3.4 | GO:0031386 | protein tag(GO:0031386) |
| 0.2 | 1.7 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.2 | 33.5 | GO:0002020 | protease binding(GO:0002020) |
| 0.2 | 3.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.2 | 1.0 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.2 | 0.7 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
| 0.2 | 1.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 0.2 | 4.3 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.2 | 93.2 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.2 | 1.4 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
| 0.2 | 0.7 | GO:0033699 | DNA 5'-adenosine monophosphate hydrolase activity(GO:0033699) |
| 0.2 | 3.0 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.2 | 0.9 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
| 0.2 | 2.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.2 | 3.9 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.2 | 0.7 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
| 0.2 | 0.5 | GO:0031696 | alpha-2C adrenergic receptor binding(GO:0031696) |
| 0.2 | 1.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.2 | 1.1 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 0.2 | 7.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.2 | 0.7 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
| 0.2 | 2.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.2 | 5.6 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.2 | 1.1 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 0.2 | 2.2 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.2 | 2.9 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.2 | 1.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.2 | 2.0 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.2 | 0.2 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
| 0.2 | 1.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.2 | 0.9 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
| 0.2 | 6.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.2 | 5.0 | GO:0001163 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.2 | 26.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.2 | 1.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.2 | 0.4 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.2 | 0.2 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 0.2 | 0.6 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.2 | 0.9 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
| 0.2 | 0.6 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.2 | 2.5 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.2 | 1.5 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
| 0.2 | 0.6 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.2 | 0.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.2 | 11.8 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.2 | 0.4 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.2 | 1.0 | GO:1902444 | riboflavin binding(GO:1902444) |
| 0.2 | 1.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.2 | 6.0 | GO:0005549 | odorant binding(GO:0005549) |
| 0.2 | 0.4 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.2 | 1.4 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.2 | 2.3 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.2 | 3.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.2 | 1.6 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.2 | 1.4 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.2 | 1.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 0.2 | 7.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.2 | 0.6 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
| 0.2 | 4.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.2 | 0.8 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.2 | 0.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.2 | 3.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.2 | 0.6 | GO:0001855 | complement component C4b binding(GO:0001855) complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
| 0.2 | 0.4 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.2 | 1.2 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 0.2 | 15.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.2 | 2.6 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.2 | 2.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.2 | 1.6 | GO:0043495 | protein anchor(GO:0043495) |
| 0.2 | 0.6 | GO:0042947 | glucoside transmembrane transporter activity(GO:0042947) |
| 0.2 | 3.9 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
| 0.2 | 0.8 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 0.2 | 0.8 | GO:0042806 | fucose binding(GO:0042806) |
| 0.2 | 1.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.2 | 2.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.2 | 0.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
| 0.2 | 8.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.2 | 0.8 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 0.2 | 0.9 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.2 | 1.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.2 | 0.7 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.2 | 2.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.2 | 0.7 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.2 | 4.2 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.2 | 7.6 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.2 | 0.7 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.2 | 0.9 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.2 | 1.9 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.2 | 0.7 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 0.2 | 11.7 | GO:0030674 | protein binding, bridging(GO:0030674) |
| 0.2 | 2.4 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.2 | 15.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.2 | 0.5 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.2 | 1.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.2 | 0.5 | GO:0032093 | SAM domain binding(GO:0032093) |
| 0.2 | 0.8 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.2 | 1.3 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.2 | 1.0 | GO:0045174 | glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
| 0.2 | 18.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.2 | 0.8 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
| 0.2 | 5.3 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
| 0.2 | 1.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.2 | 1.6 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.2 | 2.7 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.2 | 0.5 | GO:0080023 | 3R-hydroxyacyl-CoA dehydratase activity(GO:0080023) |
| 0.2 | 1.0 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.2 | 0.6 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.2 | 3.5 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.2 | 1.8 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.2 | 1.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.2 | 1.9 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
| 0.2 | 0.3 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
| 0.2 | 0.9 | GO:0008066 | glutamate receptor activity(GO:0008066) |
| 0.2 | 1.9 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.2 | 0.3 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.2 | 2.3 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.2 | 0.6 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.2 | 0.6 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.2 | 3.6 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.2 | 2.9 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.1 | 0.1 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.1 | 1.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.1 | 0.7 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 0.1 | 1.5 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
| 0.1 | 1.5 | GO:0030249 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
| 0.1 | 2.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.1 | 1.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.1 | 3.6 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.1 | 0.4 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
| 0.1 | 0.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
| 0.1 | 0.3 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
| 0.1 | 0.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.1 | 10.5 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.1 | 0.7 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.1 | 3.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.1 | 0.6 | GO:0004773 | steryl-sulfatase activity(GO:0004773) |
| 0.1 | 1.4 | GO:0017069 | snRNA binding(GO:0017069) |
| 0.1 | 0.4 | GO:0015489 | polyamine transmembrane transporter activity(GO:0015203) putrescine transmembrane transporter activity(GO:0015489) |
| 0.1 | 0.8 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.1 | 1.0 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.1 | 0.4 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
| 0.1 | 5.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.1 | 0.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.1 | 0.5 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
| 0.1 | 6.9 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.1 | 0.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.1 | 0.8 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.1 | 0.4 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.1 | 3.7 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.1 | 1.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.1 | 1.6 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.1 | 2.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.1 | 0.9 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.1 | 0.6 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.1 | 0.5 | GO:0001626 | nociceptin receptor activity(GO:0001626) |
| 0.1 | 5.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.1 | 1.0 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
| 0.1 | 9.1 | GO:0019003 | GDP binding(GO:0019003) |
| 0.1 | 0.2 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 0.1 | 0.6 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 0.1 | 3.0 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
| 0.1 | 0.4 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.1 | 4.0 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
| 0.1 | 0.2 | GO:0017171 | serine hydrolase activity(GO:0017171) |
| 0.1 | 0.6 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 0.1 | 50.2 | GO:0030695 | GTPase regulator activity(GO:0030695) |
| 0.1 | 1.1 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.1 | 2.3 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
| 0.1 | 0.3 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 0.1 | 1.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.1 | 1.0 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.1 | 2.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.1 | 0.3 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 0.1 | 2.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.1 | 0.7 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.1 | 0.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
| 0.1 | 5.2 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.1 | 0.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.1 | 1.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 0.1 | GO:0070404 | NADH binding(GO:0070404) |
| 0.1 | 0.5 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.1 | 0.1 | GO:0047115 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
| 0.1 | 10.1 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.1 | 0.3 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 0.1 | 0.6 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.1 | 2.7 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.1 | 3.5 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.1 | 0.8 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
| 0.1 | 0.4 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
| 0.1 | 1.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.1 | 5.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.1 | 0.1 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
| 0.1 | 0.2 | GO:0001129 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
| 0.1 | 1.9 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
| 0.1 | 0.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.1 | 0.2 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
| 0.1 | 1.0 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 0.1 | 2.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.1 | 0.5 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.1 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.1 | 0.1 | GO:0016972 | thiol oxidase activity(GO:0016972) |
| 0.1 | 0.7 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.1 | 2.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.1 | 0.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.1 | 5.5 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
| 0.1 | 1.7 | GO:0005521 | lamin binding(GO:0005521) |
| 0.1 | 2.2 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.1 | 0.7 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.1 | 2.6 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
| 0.1 | 0.2 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.1 | 7.5 | GO:0005179 | hormone activity(GO:0005179) |
| 0.1 | 2.1 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.1 | 10.5 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
| 0.1 | 0.9 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 0.1 | 0.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.1 | 1.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.1 | 0.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
| 0.1 | 1.0 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.1 | 0.3 | GO:0052854 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
| 0.1 | 0.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.1 | 0.4 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.1 | 0.5 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.1 | 1.1 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.1 | 1.6 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.1 | 1.5 | GO:0005112 | Notch binding(GO:0005112) |
| 0.1 | 0.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 0.1 | 0.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 0.8 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.1 | 1.8 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.1 | 1.6 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.1 | 0.3 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.1 | 0.2 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
| 0.1 | 0.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.1 | 1.5 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.1 | 0.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.1 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) |
| 0.1 | 0.5 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.1 | 0.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.1 | 1.7 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.1 | 0.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.1 | 0.3 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
| 0.1 | 0.7 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
| 0.1 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.1 | 0.4 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
| 0.1 | 0.4 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 0.1 | 0.3 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.1 | 13.5 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.1 | 0.5 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.1 | 0.7 | GO:0035240 | dopamine binding(GO:0035240) |
| 0.1 | 0.8 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.1 | 0.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.1 | 17.7 | GO:0005198 | structural molecule activity(GO:0005198) |
| 0.1 | 0.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.1 | 0.4 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.1 | 0.7 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
| 0.1 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
| 0.1 | 0.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.1 | 0.2 | GO:0030298 | receptor signaling protein tyrosine kinase activator activity(GO:0030298) |
| 0.1 | 0.6 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.1 | 0.1 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.1 | 0.3 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.1 | 2.6 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
| 0.1 | 0.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.1 | 0.9 | GO:0035254 | glutamate receptor binding(GO:0035254) |
| 0.1 | 0.6 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.1 | 0.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.1 | 0.2 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.1 | 4.9 | GO:0019902 | phosphatase binding(GO:0019902) |
| 0.1 | 0.2 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
| 0.1 | 1.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.1 | 0.4 | GO:1900750 | oligopeptide binding(GO:1900750) |
| 0.1 | 2.0 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.0 | 2.1 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.0 | 0.2 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.0 | 0.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.0 | 0.3 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 0.0 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.0 | 0.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.0 | 0.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.0 | 8.6 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
| 0.0 | 0.9 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.0 | 0.0 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
| 0.0 | 0.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.0 | 0.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
| 0.0 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
| 0.0 | 1.4 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.0 | 0.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.0 | 0.4 | GO:0045182 | translation regulator activity(GO:0045182) |
| 0.0 | 0.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.0 | 4.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.0 | 0.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.0 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.0 | 0.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.0 | 0.1 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.0 | 3.2 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.0 | 0.0 | GO:0047750 | cholestenol delta-isomerase activity(GO:0047750) |
| 0.0 | 0.1 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
| 0.0 | 0.2 | GO:0016594 | glycine binding(GO:0016594) |
| 0.0 | 2.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.0 | 0.1 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.0 | 0.4 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
| 0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 0.0 | 0.1 | GO:0042008 | interleukin-18 receptor activity(GO:0042008) |
| 0.0 | 1.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.0 | 0.2 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
| 0.0 | 0.1 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
| 0.0 | 0.1 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.0 | 0.8 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.0 | 0.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.0 | 0.1 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 0.0 | 0.3 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
| 0.0 | 0.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.0 | 0.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
| 0.0 | 0.0 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
| 0.0 | 0.1 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.0 | 0.1 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.0 | 0.6 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.0 | 0.2 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.0 | 0.1 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 0.0 | 0.1 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.0 | 0.1 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.0 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.0 | 0.1 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.0 | 0.7 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.5 | 95.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 1.1 | 20.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 1.0 | 17.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 1.0 | 36.7 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.9 | 13.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.9 | 10.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.9 | 4.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.9 | 61.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.8 | 20.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.7 | 16.8 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.7 | 28.4 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.7 | 0.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.7 | 37.7 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.6 | 44.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.6 | 17.7 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.6 | 0.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.6 | 18.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.6 | 36.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.6 | 0.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.6 | 2.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.6 | 13.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.6 | 4.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.6 | 11.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.6 | 42.7 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.6 | 1.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.6 | 18.1 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.6 | 11.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.6 | 29.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.5 | 22.2 | PID IGF1 PATHWAY | IGF1 pathway |
| 0.5 | 21.0 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.5 | 2.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.5 | 165.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.5 | 1.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.5 | 8.8 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.5 | 19.4 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.5 | 15.0 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.5 | 3.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.4 | 16.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.4 | 15.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.4 | 6.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.4 | 3.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.4 | 7.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.4 | 0.8 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.4 | 19.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.4 | 8.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.4 | 16.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.4 | 7.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.4 | 2.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.4 | 11.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.4 | 24.7 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.4 | 7.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.4 | 4.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.4 | 13.4 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.3 | 8.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.3 | 3.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.3 | 1.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.3 | 3.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.3 | 11.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.3 | 8.2 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.3 | 29.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.3 | 1.8 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.3 | 0.3 | ST ADRENERGIC | Adrenergic Pathway |
| 0.3 | 2.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.3 | 1.7 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.3 | 0.6 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.3 | 3.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.3 | 13.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.3 | 4.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.3 | 5.1 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.3 | 1.6 | PID MYC PATHWAY | C-MYC pathway |
| 0.3 | 7.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.3 | 5.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.3 | 7.7 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.3 | 3.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.2 | 8.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.2 | 1.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.2 | 4.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.2 | 3.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.2 | 5.6 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.2 | 1.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.2 | 53.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.2 | 0.7 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.2 | 81.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.2 | 3.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.2 | 1.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.2 | 12.0 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.2 | 1.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.2 | 6.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.2 | 6.4 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.2 | 2.6 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.2 | 3.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.2 | 9.5 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.2 | 1.6 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.2 | 0.8 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.2 | 2.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.2 | 5.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.1 | 7.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.1 | 6.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.1 | 2.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.1 | 4.0 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.1 | 1.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.1 | 5.8 | PID ATR PATHWAY | ATR signaling pathway |
| 0.1 | 1.8 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.1 | 4.7 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.1 | 11.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.1 | 0.8 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.1 | 2.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.1 | 0.9 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.1 | 2.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.1 | 23.2 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
| 0.1 | 8.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.1 | 0.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.1 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.1 | 0.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 0.1 | 0.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.1 | 4.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.1 | 0.8 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.1 | 2.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 1.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.1 | 2.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.1 | 2.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.1 | 1.3 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.1 | 1.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.0 | 2.1 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.0 | 1.0 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
| 0.0 | 0.7 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.0 | 0.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.0 | 0.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.0 | 0.5 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.0 | 0.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.0 | 0.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 0.6 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.3 | 4.0 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 1.2 | 27.9 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 1.2 | 1.2 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
| 1.1 | 1.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 1.1 | 42.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 1.0 | 20.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 1.0 | 18.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.9 | 6.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.9 | 22.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.9 | 11.0 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.9 | 4.5 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.9 | 55.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.8 | 0.8 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.8 | 0.8 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
| 0.8 | 23.4 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.8 | 0.8 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
| 0.8 | 28.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.7 | 5.1 | REACTOME SEMAPHORIN INTERACTIONS | Genes involved in Semaphorin interactions |
| 0.7 | 14.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.7 | 11.9 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.7 | 11.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.7 | 14.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.7 | 14.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.7 | 10.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.7 | 25.0 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
| 0.7 | 20.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.7 | 7.8 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.6 | 7.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.6 | 18.8 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.6 | 21.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.6 | 18.3 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.6 | 18.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.6 | 1.8 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.6 | 1.2 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
| 0.6 | 23.6 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.6 | 39.5 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.6 | 14.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.6 | 7.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.6 | 14.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.6 | 10.1 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
| 0.6 | 30.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.6 | 9.9 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.5 | 41.9 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
| 0.5 | 13.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.5 | 0.5 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.5 | 16.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.5 | 19.7 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
| 0.5 | 0.5 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 0.5 | 22.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.5 | 13.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.5 | 14.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.5 | 10.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.5 | 11.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.5 | 50.5 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.4 | 18.8 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.4 | 6.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.4 | 7.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.4 | 10.6 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.4 | 6.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.4 | 7.8 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.4 | 6.4 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.4 | 13.2 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.4 | 6.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.4 | 6.4 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.4 | 14.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.4 | 17.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.4 | 3.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.4 | 4.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.4 | 12.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.4 | 8.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.4 | 14.9 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.4 | 0.7 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.4 | 6.2 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.4 | 13.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.4 | 7.9 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.4 | 4.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.4 | 5.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.4 | 7.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.3 | 2.1 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.3 | 7.3 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.3 | 8.3 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.3 | 5.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.3 | 6.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.3 | 12.4 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.3 | 21.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.3 | 8.6 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 0.3 | 8.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.3 | 0.3 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
| 0.3 | 0.9 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.3 | 9.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.3 | 5.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.3 | 6.9 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.3 | 24.8 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.3 | 1.5 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.3 | 9.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.3 | 5.8 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.3 | 2.9 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.3 | 7.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.3 | 2.0 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.3 | 0.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 0.3 | 5.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.3 | 6.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.3 | 3.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.3 | 0.5 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
| 0.3 | 4.0 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.3 | 17.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.3 | 2.1 | REACTOME DEFENSINS | Genes involved in Defensins |
| 0.3 | 3.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.3 | 2.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.3 | 0.5 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 0.3 | 10.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.3 | 3.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.3 | 5.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.2 | 0.7 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
| 0.2 | 14.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.2 | 10.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.2 | 3.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.2 | 2.2 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.2 | 14.4 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
| 0.2 | 6.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.2 | 17.1 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.2 | 3.1 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
| 0.2 | 4.0 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.2 | 2.8 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.2 | 2.8 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.2 | 26.0 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.2 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.2 | 1.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.2 | 1.0 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.2 | 3.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.2 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.2 | 13.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.2 | 4.6 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
| 0.2 | 7.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.2 | 5.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.2 | 3.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.2 | 0.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.2 | 3.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.2 | 2.3 | REACTOME OPSINS | Genes involved in Opsins |
| 0.2 | 3.5 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.2 | 2.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.2 | 1.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.2 | 1.0 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.2 | 28.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.2 | 3.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.2 | 0.5 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
| 0.2 | 2.7 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.2 | 15.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.2 | 0.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.2 | 3.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.2 | 4.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.2 | 16.5 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.1 | 2.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.1 | 2.8 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.1 | 2.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.1 | 1.7 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
| 0.1 | 2.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.1 | 7.5 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
| 0.1 | 4.6 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
| 0.1 | 19.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 1.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.1 | 5.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.1 | 2.0 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.1 | 6.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.1 | 0.3 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
| 0.1 | 1.9 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
| 0.1 | 1.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.1 | 0.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.1 | 3.8 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
| 0.1 | 2.6 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
| 0.1 | 1.7 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.1 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.1 | 1.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.1 | 0.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.1 | 1.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.1 | 1.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.1 | 5.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.1 | 1.2 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.1 | 1.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.1 | 0.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.1 | 1.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.1 | 4.7 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.1 | 0.9 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.1 | 2.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.1 | 0.9 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.1 | 5.8 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.1 | 0.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.1 | 4.1 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.1 | 2.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.1 | 0.3 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.1 | 1.1 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
| 0.1 | 4.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.1 | 1.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.1 | 2.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.1 | 1.1 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.1 | 6.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.1 | 1.0 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.1 | 0.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
| 0.1 | 0.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.1 | 0.8 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
| 0.1 | 4.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.1 | 0.5 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.1 | 9.4 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.1 | 5.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.1 | 1.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.1 | 1.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.1 | 1.0 | REACTOME TRANSLATION | Genes involved in Translation |
| 0.1 | 1.0 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
| 0.1 | 0.1 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
| 0.1 | 0.9 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.0 | 1.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
| 0.0 | 0.8 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.0 | 1.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.0 | 0.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
| 0.0 | 1.2 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.0 | 1.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.0 | 0.5 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
| 0.0 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.0 | 0.2 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
| 0.0 | 0.7 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
| 0.0 | 0.9 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
| 0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.0 | 2.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.0 | 2.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.0 | 0.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.0 | 0.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.0 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
| 0.0 | 0.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.0 | 0.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.0 | 0.2 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.0 | 0.3 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.0 | 0.4 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
| 0.0 | 0.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.0 | 0.3 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |